1
|
Vo AT, Ta KNT, Chuang KJ. Comparative effectiveness of pharmacological and non-pharmacological interventions for dyspnea management in advanced cancer: A systematic review and network meta-analysis. Asia Pac J Oncol Nurs 2025; 12:100671. [PMID: 40129487 PMCID: PMC11931311 DOI: 10.1016/j.apjon.2025.100671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Accepted: 02/13/2025] [Indexed: 03/26/2025] Open
Abstract
Objective This study aimed to evaluate and rank the effectiveness of pharmacological and non-pharmacological interventions for managing dyspnea severity, anxiety, exercise capacity, and health-related quality of life (HRQoL) in patients with advanced cancer. Methods A comprehensive search of PUBMED, HINARI, CENTRAL, and ResearchGate was conducted to identify randomized controlled trials (RCTs) published up to March 2024. Network meta-analysis was performed to compare interventions, calculating mean differences (MD) and standardized mean differences (SMD) with 95% confidence intervals (CI). P-scores were used to rank the interventions. Risk of bias was assessed using the Cochrane tool, and the quality of evidence (QOE) was evaluated using the GRADE framework. Results A total of 42 RCTs, encompassing 3,832 patients, were included in the analysis. Among the evaluated interventions, high-flow nasal cannula (HFNC) demonstrated the most significant improvement in dyspnea relief (SMD = -1.91; 95% CI: -3.32 to -0.49; QOE: moderate), followed by acupressure/reflexology (SMD = -1.04; 95% CI: -2.02 to -0.06; QOE: very low). Activity rehabilitation was the only intervention that significantly reduced anxiety compared to the control group (SMD = -0.64; 95% CI: -0.97 to -0.32; QOE: very low). While all interventions showed trends of improving exercise capacity, none reached statistical significance. Notably, acupressure/reflexology significantly enhanced HRQoL (SMD = 1.55; 95% CI: 0.22 to 2.88; QOE: moderate). Conclusions Non-pharmacological interventions, particularly HFNC and acupressure/reflexology, were more effective than pharmacological approaches in improving dyspnea relief and HRQoL. However, the low quality of evidence underscores the need for high-quality, large-scale trials to confirm these findings and refine treatment strategies for dyspnea management in advanced cancer patients. Systematic review registration PROSPERO CRD42023479041.
Collapse
Affiliation(s)
- An Thuy Vo
- Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam
| | - Kim-Ngan Thi Ta
- Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam
| | - Kai-Jen Chuang
- Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, New Taipei, Taiwan
- School of Public Health, College of Public Health, Taipei Medical University, New Taipei, Taiwan
| |
Collapse
|
2
|
Mahmoudjafari Z, Li J, Bercaw E, Parisé H, Bognar K, Wang ST, Masaquel A. Budget impact of introducing glofitamab for treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy in the United States. J Med Econ 2025; 28:595-604. [PMID: 40163049 DOI: 10.1080/13696998.2025.2486839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Accepted: 03/27/2025] [Indexed: 04/02/2025]
Abstract
BACKGROUND Glofitamab is a T-cell engaging bispecific monoclonal antibody that was granted accelerated approval from the United States Food and Drug Administration for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified or large B-cell lymphoma arising from follicular lymphoma, after ≥2 lines of systemic therapy (3L+). METHODS A budget impact model was developed for a hypothetical blended commercial/Medicare health plan with 1,000,000 members. Comparators were axicabtagene ciloleucel (Axi-cel), lisocabtagene maraleucel (Liso-cel), tisagenlecleucel (Tisa-cel), loncastuximab tesirine, polatuzumab vedotin + bendamustine + rituximab, rituximab + gemcitabine + oxaliplatin, tafasitamab + lenalidomide, and epcoritamab (Epcor). Total costs included those for drugs, wastage, administration, grade ≥3 adverse reactions, and all-grade cytokine release syndrome) and routine care. Market shares were based on internal projections and expert opinions. Total and per-member per-month (PMPM) net budget impacts over 3 years were calculated. RESULTS Approximately nine patients were projected to be eligible for 3L + DLBCL treatment in a health plan of 1,000,000 members. The introduction of glofitamab as a treatment option resulted in estimated total and PMPM cost savings of $728,697 and -$0.0202, respectively, over 3 years. Costs were reduced across all cost categories but particularly in drug costs. Among the newer therapies, total 3-year cost per treated patient was lowest for glofitamab: $226,658 versus Tisa-cel = $564,113; Axi-cel = $540,002; Liso-cel = $516,272; and Epcor = $335,293. Across all sensitivity analyses, the inclusion of glofitamab had minimal PMPM budget impact, ranging from -$0.0256 to -$0.0108. CONCLUSIONS With the lowest 3-year total cost per treated patient among the newer therapies, glofitamab being an available option in the 3L + DLBCL market is estimated to save a hypothetical 1,000,000-member health plan $728,697 in cumulative total costs and $0.0202 in PMPM costs over 3 years.
Collapse
Affiliation(s)
| | - Jia Li
- Genentech, Inc, South San Francisco, CA, USA
| | | | | | | | | | | |
Collapse
|
3
|
Lu S, Zhang Y, Wei S, Li J, Li M, Ying J, Mu D, Shi Y, Li Y, Wu X. Extracorporeal membrane oxygenation in pregnancy and the post-partum period: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2025; 38:2457002. [PMID: 39880582 DOI: 10.1080/14767058.2025.2457002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 01/10/2025] [Accepted: 01/15/2025] [Indexed: 01/31/2025]
Abstract
OBJECTIVE There is an increase in the application data of Extracorporeal Membrane Oxygenation (ECMO) in perinatal women, particularly since the outbreak of coronavirus disease 2019. Therefore, we reviewed publications on the use of ECMO in pregnant and postpartum women and analyzed the maternal and fetal outcomes, updated the progress of ECMO in perinatal women. METHODS We conducted a systematic literature search across PubMed, EMBASE, Cochrane Library, and the International Clinical Trials Registry (ICTRP), yielding 30 eligible clinical studies that investigated the application of ECMO during pregnancy. A comprehensive data extraction process was implemented to retrieve information from these selected studies. A single rate analysis on material survival, material harmonic compilations, and fetus survival were performed by R software. RESULTS Of the 1460 women included, our primary outcome was maternal survival: 74.4% (95% confidence interval [CI]: 67.8%-81.1%). Among them, the survival rate of VV ECMO patients was 83.6% (95% confidence interval [CI]: 76.4%-90.8%); the survival rate of VA ECMO patients was 62.8% (95% confidence interval [CI]: 48.7%-76.8%). The secondary outcomes were maternal hemorrhagic complications: 34.8% (95% [CI]: 24.1%-45.5%), and fetal survival: 73.2% (95% [CI]: 62.0%-84.4%). CONCLUSIONS Our analysis revealed that the outcomes of ECMO (both type) use in pregnant patients may be comparable or superior to those observed in non-pregnant cohorts. Moreover, patients treated with VV ECMO exhibited a significantly higher survival rate compared to those on VA ECMO. DETAILS OF REGISTRATION The protocol for this systematic review was registered on INPLASY (2022110036) in 11 November 2022.
Collapse
Affiliation(s)
- Sijie Lu
- Second Clinical Medical College, Lanzhou University, Lanzhou, China
| | - Yantao Zhang
- Second Clinical Medical College, Lanzhou University, Lanzhou, China
| | - Shilin Wei
- Second Clinical Medical College, Lanzhou University, Lanzhou, China
| | - Jian Li
- Second Clinical Medical College, Lanzhou University, Lanzhou, China
| | - Mingming Li
- Department of Neurology, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China
| | - Junjie Ying
- Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China
| | - Dezhi Mu
- Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China
| | - Yujun Shi
- Department of Anesthesiology, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China
| | - Yongnan Li
- Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China
| | - Xiangyang Wu
- Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China
| |
Collapse
|
4
|
Portaro S, Alito A, Leonardi G, Marotta N, Tisano A, Bruschetta D, Longo UG, Ammendolia A, Milardi D, de Sire A. Efficacy of neuromodulation and rehabilitation approaches on pain relief in patients with spinal cord injury: a systematic review and meta-analysis. Neurol Sci 2025; 46:2995-3020. [PMID: 40067404 DOI: 10.1007/s10072-025-08077-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2025] [Accepted: 02/19/2025] [Indexed: 06/11/2025]
Abstract
INTRODUCTION Spinal cord injury (SCI) is a debilitating neurological condition that causes physical dependency, psychological distress, and financial burden. Pain is a common consequence of SCI, significantly impacting quality of life. Effective pain management in SCI is challenging and requires multifaceted approaches. Among rehabilitation methods, non-invasive brain stimulation techniques such as repetitive transcranial magnetic stimulation (rTMS), theta burst stimulation (TBS), transcranial direct current stimulation (tDCS), transcutaneous electrical nerve stimulation (TENS), and virtual reality (VR) have been explored. This study aims to evaluate the efficacy of rehabilitation and non-invasive brain stimulation techniques on pain relief in SCI patients. METHODS A systematic review of the literature was conducted using PubMed, Scopus, and ScienceDirect with the formula ("spinal cord injury") AND ("pain"). Risk of bias was assessed using the Cochrane Risk of Bias Tool. RESULTS Sixteen studies involving 319 patients were included. Patients in the control groups received: rTMS in seven trials, tDCS in seven trials, TBS in one trial, and TENS combined with VR in one trial. The trials analyzed were of poor methodological quality, characterized by small sample sizes, weak power analyses, varying clinical scores, and non-comparable follow-up periods. No major complications or serious adverse events were reported. CONCLUSION Results were inconsistent, with no solid evidence supporting the superiority of rehabilitation techniques over comparator treatments. However, the favorable safety profile and positive outcomes in some measures suggest potential benefits for pain management and quality of life. Further studies are necessary to better understand SCI-related pain and optimize treatment strategies.
Collapse
Affiliation(s)
- Simona Portaro
- Department of Physical and Rehabilitation Medicine, University Hospital "G. Martino", Messina, Italy
| | - Angelo Alito
- Department of Biomedical, Dental Sciences and Morphological and Functional Images, University of Messina, Messina, Italy
| | - Giulia Leonardi
- Department of Physical and Rehabilitation Medicine, University Hospital "G. Martino", Messina, Italy
| | - Nicola Marotta
- Physical Medicine and Rehabilitation Unit, Department of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy
- Research Center on Musculoskeletal Health, MusculoSkeletalHealth@UMG, University of Catanzaro "Magna Graecia", Catanzaro, Italy
| | - Adriana Tisano
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - Daniele Bruschetta
- Department of Biomedical, Dental Sciences and Morphological and Functional Images, University of Messina, Messina, Italy
| | - Umile Giuseppe Longo
- Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
- Research Unit of Orthopaedic and Trauma Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Rome, Italy
| | - Antonio Ammendolia
- Research Center on Musculoskeletal Health, MusculoSkeletalHealth@UMG, University of Catanzaro "Magna Graecia", Catanzaro, Italy
- Physical Medicine and Rehabilitation Unit, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy
| | - Demetrio Milardi
- Department of Biomedical, Dental Sciences and Morphological and Functional Images, University of Messina, Messina, Italy
| | - Alessandro de Sire
- Research Center on Musculoskeletal Health, MusculoSkeletalHealth@UMG, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
- Physical Medicine and Rehabilitation Unit, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
| |
Collapse
|
5
|
Dost B, Bugada D, Karapinar YE, Balzani E, Beldagli M, Aviani Fulvio G, Yalin MSO, Turunc E, Sella N, De Cassai A. Paravertebral block is not superior to the interpectoral and pectoserratus plane block for patients undergoing breast surgery: An updated meta-analysis of randomised controlled trials with meta-regression and trial sequential analysis. Eur J Anaesthesiol 2025; 42:637-648. [PMID: 39935244 DOI: 10.1097/eja.0000000000002148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2024] [Accepted: 01/26/2025] [Indexed: 02/13/2025]
Abstract
BACKGROUND Breast surgery is frequently associated with significant acute postoperative pain, necessitating effective pain management strategies. Both thoracic paravertebral block (PVB) and interpectoral plane and pectoserratus plane (IP+PS) blocks have been used to relieve pain after breast surgery. OBJECTIVE In this systematic review and meta-analysis with trial sequential analysis, we aimed to identify the optimal analgesic technique for achieving effective pain relief in breast surgery. The primary outcome of this study was postoperative opioid consumption expressed as morphine milligram equivalent (MME) at 24 h. Secondary outcomes included resting and movement pain scores at 0, 6, 12 and 24 h, postoperative nausea and vomiting (PONV), and rescue analgesic requirements within the first 24 h. DESIGN A meta-analysis of randomised controlled trials (RCTs) with meta-regression and trial sequential analysis (TSA). DATA SEARCH We systematically searched Pubmed, Scopus, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, Google Scholar, Medline (from inception to until 1 October 2024). ELIGIBILITY CRITERIA RCTs that include patients undergoing breast surgery with PVB or IP+PS block, with no language restriction. RESULTS Eighteen RCTs with 924 patients were included. No significant difference in MME consumption at 24 h was observed between the two techniques; mean difference (MD) -1.94 (95% confidence interval (CI) -4.27 to 0.38, P = 0.101). Subgroup analyses revealed a minor advantage for IP+PS in patients without axillary involvement; MD -2.42 (95% CI -3.56 to -1.29, P < 0.001), though below the threshold of clinical significance. Secondary outcomes, including pain scores, PONV incidence and rescue analgesic requirements were comparable. Trial sequential analysis (TSA) confirmed sufficient sample size, suggesting further studies may not alter conclusions. CONCLUSION PVB and IP+PS blocks offer comparable analgesic efficacy and opioid-sparing effects after breast surgery, with no meaningful differences in 24-h MME consumption, pain scores, or PONV incidence.
Collapse
Affiliation(s)
- Burhan Dost
- From the Department of Anesthesiology and Reanimation, Ondokuz Mayis University Faculty of Medicine, Samsun, Türkiye (BD, ET), Department of Emergency and Critical Care Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy (DB), Department of Anesthesiology and Reanimation, Ataturk University School of Medicine, Erzurum, Türkiye (YEK, MSOY), Department of Surgical Science, University of Turin, Torino, Italy (EB), Department of Anesthesiology and Reanimation, Samsun Training and Research Hospital, Samsun, Türkiye (MB), Department of Medicine (DIMED), University of Padua, Padua, Italy (GAF, ADC), and Institute of Anesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy (NS, ADC)
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Jain N, McKeeman J, Schultz K, Chan W, Aaron D, Busconi B, Smith T. Tranexamic acid use in rotator cuff repair: A systematic review of perioperative outcomes. J Orthop 2025; 65:119-125. [PMID: 39867651 PMCID: PMC11754154 DOI: 10.1016/j.jor.2024.12.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Accepted: 12/23/2024] [Indexed: 01/28/2025] Open
Abstract
Background Tranexamic acid (TXA) use has become the gold standard in total joint arthroplasty to limit intraoperative blood loss and transfusion rates. More recently, the indications for TXA have expanded to knee and shoulder arthroscopy with promising early results. However, the effectiveness of TXA during arthroscopic rotator cuff repair (RCR) is unclear. Therefore, the purpose of this study was to investigate perioperative outcomes following the use of TXA during RCR. Methods A systematic review was performed via the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using PubMed, MEDLINE, Embase, and Cochrane databases in November 2024. Studies were assessed for quality of visual clarity, operative time, mean arterial pressure (MAP), volume of arthroscopy irrigation used, arthroscopic pump pressure, and clinical outcomes. Results A total of 12 clinical trials involving 999 patients were included. 9 studies reported on visual clarity and 6 of these reported improvements in visual clarity with TXA administration. Four studies reported improvements in postoperative pain, however outcomes varied greatly depending on when follow-up assessment occurred. A majority of studies did not report differences in operative time, irrigation volume, or postoperative swelling. There were no venous thromboembolism events reported in the included studies. Conclusion TXA dosing during RCR surgery may improve visual clarity, however its effect on other perioperative outcomes remains unclear. Level of evidence Level I.
Collapse
Affiliation(s)
- Neil Jain
- Department of Orthopaedic Surgery, St. Luke's University Health Network, Bethlehem, PA, USA
| | - Jonathan McKeeman
- Department of Orthopaedic Surgery, St. Luke's University Health Network, Bethlehem, PA, USA
| | - Kyle Schultz
- Department of Orthopaedic Surgery, Orthopedic and Sports Medicine Center, Granger, IN, USA
| | - Wayne Chan
- Department of Orthopaedic Surgery, University of Massachusetts Memorial Medical Center, Worcester, MA, USA
| | - Daniel Aaron
- Department of Orthopaedic Surgery, University of Massachusetts Memorial Medical Center, Worcester, MA, USA
| | - Brian Busconi
- Department of Orthopaedic Surgery, University of Massachusetts Memorial Medical Center, Worcester, MA, USA
| | - Tyler Smith
- Department of Orthopaedic Surgery, St. Luke's University Health Network, Bethlehem, PA, USA
| |
Collapse
|
7
|
Liu Y, Zhou L, Wang X. The Efficacy of Intravenous Analgesia and Various Nerve Blocks for Pain Management in Elderly Patients With Hip Fractures: A Meta-Analysis. Orthop Surg 2025. [PMID: 40491168 DOI: 10.1111/os.70090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2025] [Revised: 04/13/2025] [Accepted: 05/23/2025] [Indexed: 06/11/2025] Open
Abstract
Pain management in elderly patients with hip fractures has received more and more attention, which is crucial for promoting recovery and reducing complications. At present, there are various and controversial analgesic methods for this population. This meta-analysis evaluated the analgesic effects and side effects of intravenous analgesia compared to different nerve block techniques, including femoral nerve block, fascia iliaca block or pericapsular nerve group block, in this patient group. The study was conducted following the PRISMA 2020 guidelines. A search was performed in October 2024 across PubMed, Web of Science, Cochrane Library, and Embase. Pain scores at different time points, supplemental analgesic morphine consumption, and adverse reactions were compared between intravenous analgesia and nerve blocks. Data were collected from 12 studies and 1157 elderly patients using intravenous analgesia and nerve block after hip fracture, with no differences in sample size, mean age, or percentage of females between the two groups at baseline. Compared to intravenous analgesia, nerve blocks showed significant advantages in the pain score of 2 h after block (SMD-0.80; 95% CI: -1.23 to -0.38; I2 = 90%) and the supplemental analgesic morphine consumption (SMD = -0.46; 95% CI: -0.73 to -0.19; I2 = 59%). The incidence of adverse reactions and the pain scores at various time points also demonstrated significant differences between the two groups. The application of nerve blocks in elderly patients with hip fractures demonstrates significant clinical advantages, particularly in postoperative pain management, decreasing opioid use, and reducing postoperative complications.
Collapse
Affiliation(s)
- Yuping Liu
- Department of Anesthesiology, West China Second University Hospital, Sichuan University, Sichuan, China
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Sichuan, China
- Department of Anesthesiology, Chengdu Hi-Tech Zone Hospital for Women and Children, Chengdu, China
| | - Li Zhou
- Department of Anesthesiology, West China Second University Hospital, Sichuan University, Sichuan, China
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Sichuan, China
- Department of Anesthesiology, Chengdu Hi-Tech Zone Hospital for Women and Children, Chengdu, China
| | - Xin Wang
- Department of Orthopedics Trauma and Microsurgery, Elderly Hip Fracture Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, China
| |
Collapse
|
8
|
Yamashita Y, Baudo M, Magouliotis DE, Sicouri S, Wertan MAC, Spragan DD, Torregrossa G, Ramlawi B, Sutter FP. Effect of del Nido Cardioplegia on Isolated Coronary Artery Bypass Grafting: A Study-level Meta-analysis. J Cardiothorac Vasc Anesth 2025; 39:1538-1546. [PMID: 39909765 DOI: 10.1053/j.jvca.2025.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/20/2024] [Revised: 12/11/2024] [Accepted: 01/08/2025] [Indexed: 02/07/2025]
Abstract
The purpose of this study was to evaluate the effect of del Nido cardioplegia versus conventional cardioplegic solutions on early outcomes of isolated coronary artery bypass grafting (CABG). PubMed, Scopus, and the Cochrane Central Register of Controlled Trials were searched through July 2024 to conduct a meta-analysis for a comparison between del Nido and other cardioplegic solutions in isolated CABG. Major end points of the study included operative mortality and morbidities. A random effects model was used to estimate the pooled effect size. For subgroup analyses, meta-analyses were conducted for outcomes derived from either randomized controlled-trials, propensity score analysis, or multivariable analysis. Twenty-four studies met our eligibility criteria, including 4 randomized controlled trials and 5 propensity score-matched studies with a total of 34,737 patients. Operative mortality was not significantly associated with cardioplegic solutions (del Nido vs other solutions; p = 0.262). The incidence of postoperative stroke, reoperation, deep wound infection, and atrial fibrillation was also comparable between the 2 groups. The incidence of postoperative myocardial infarction and renal failure was significantly lower in the del Nido group with a pooled odds ratio of 0.43 (95% confidence interval, 0.24-0.77) and 0.61 (95% confidence interval, 0.45-0.81), respectively. Subgroup analyses also demonstrated these significant differences. In patients undergoing isolated CABG, del Nido cardioplegia provides comparable mortality compared with other cardioplegic solutions. Del Nido solution was significantly protective against myocardial infarction and renal failure.
Collapse
Affiliation(s)
- Yoshiyuki Yamashita
- Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA; Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA.
| | - Massimo Baudo
- Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA
| | - Dimitrios E Magouliotis
- Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA
| | - Serge Sicouri
- Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA
| | - Marry Ann C Wertan
- Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA
| | - Danielle D Spragan
- Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA
| | - Gianluca Torregrossa
- Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA
| | - Basel Ramlawi
- Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA; Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA
| | - Francis P Sutter
- Department of Cardiothoracic Surgery, Lankenau Heart Institute, Wynnewood, PA, USA
| |
Collapse
|
9
|
Li T, Zheng Q, Xu J, Li Y, Zhang M, Zhang B, Zhou L, Tian J. Comparison of 11 Formulas and Breastfeeding for Atopic Dermatitis and Growth in Pediatric Cow's Milk Protein Allergy: A Systematic Review and Network Meta-Analysis of 23 Randomized Controlled Trials. J Evid Based Med 2025; 18:e70026. [PMID: 40178916 DOI: 10.1111/jebm.70026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2024] [Revised: 02/20/2025] [Accepted: 03/20/2025] [Indexed: 04/05/2025]
Abstract
OBJECTIVE This study aimed to evaluate the effectiveness of various formulas and the ability of breastfeeding with the exclusion of cow milk protein to reduce the Scoring Atopic Dermatitis (SCORAD) index and promote growth in infants with cow milk protein allergy. METHODS We conducted a systematic search of PubMed, Embase, Web of Science, the Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, China National Knowledge Infrastructure, WanFang Data, Weipu, and the China Biomedical Literature Database. The search period ranged from the inception of each database to December 2023 (with an update until January 15, 2025). We included randomized controlled trials (RCTs) comparing formulas and breastfeeding for cow's milk protein allergy in infants. Two independent reviewers extracted data via standardized methods and assessed the risk of bias via the revised Cochrane risk-of-bias 2.0 tool. We performed a network meta-analysis (NMA) via a Bayesian fixed-effects model in RStudio and assessed the certainty of the evidence via the Confidence in Network Meta-Analysis (CINeMA) online application. The protocol for this NMA was preregistered in PROSPERO (No. CRD42024504707). RESULTS This analysis included 23 RCTs involving 1997 children and assessed 12 interventions. Compared with the regular formula, the pectin-thickened amino acid formula (TAAF) might reduce the SCORAD index (-12.49, 95% confidence interval [CI] -20.38 to -4.48, low certainty). At ≤6 months of follow-up, compared with rice-hydrolyzed formula (RHF), breastfeeding might improve the length-for-age Z score (LAZ) (0.47, 95% CI 0.13-0.81, moderate certainty), and breastfeeding (0.39, 95% CI 0.02-0.77, low certainty) and extensively hydrolyzed formula (EHF) with probiotics (0.38, 95% CI 0.00-0.77, low certainty) might respectively improve the weight-for-age Z score (WAZ) and weight-for-length Z score (WLZ). At the 12-month follow-up, EHF might improve the LAZ (0.41, 95% CI 0.11-0.71, low certainty) and WLZ (0.37, 95% CI 0.18-0.56, low certainty) compared with RHF, whereas the amino acid formula (AAF) may improve the WAZ (0.33, 95% CI 0.02-0.63, low certainty). CONCLUSIONS Low-certainty evidence suggested that TAAF might reduce the SCORAD index. Moderate or low certainty evidence indicated that, at ≤6 months of follow-up, breastfeeding might improve the LAZ and WAZ, whereas EHF with probiotics might improve the WLZ. At the 12-month follow-up, EHF might improve the LAZ and WLZ, whereas AAF might improve the WAZ. However, further high-quality studies would be needed to confirm these findings and assess their safety and cost-effectiveness.
Collapse
Affiliation(s)
- Tengfei Li
- School of Nursing, Gansu University of Chinese Medicine, Lanzhou, Gansu, China
- Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
| | - Qingyong Zheng
- Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
| | - Jianguo Xu
- Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
| | - Yiyi Li
- School of Nursing, Gansu University of Chinese Medicine, Lanzhou, Gansu, China
| | - Mingyue Zhang
- Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
| | - Bowa Zhang
- School of Nursing, Gansu University of Chinese Medicine, Lanzhou, Gansu, China
| | - Li Zhou
- Department of Pediatric Gastroenterology, Gansu Province Maternity and Child Health Hospital, Gansu Province Central Hospital, Lanzhou, Gansu, China
| | - Jinhui Tian
- Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
| |
Collapse
|
10
|
Zedde M, Pascarella R. Spinal cord involvement in primary central nervous system vasculitis. A systematic review of clinical, neuroradiological and pathological findings. Neurol Sci 2025; 46:2523-2538. [PMID: 39979764 DOI: 10.1007/s10072-025-08007-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2024] [Accepted: 01/12/2025] [Indexed: 02/22/2025]
Abstract
INTRODUCTION Primary Angiitis of Central Nervous System (PACNS) is a rare disease featured by transmural inflammation in vessels pertaining to brain, leptomeninges and spinal cord. It is a rare disease and the involvement of the spinal cord represents a rarer and not yet completely investigated subtype. METHODS We performed a systematic search of the available literature on Pubmed and Embase, adding backward and forward citations, in order to retrieve the reported cases of PACNS i9nvolvimeng the spinal cord without time limitations. The main aim is to retrieve information about clinical and demographic features, pathological and neuroradiological findings on brain and spinal cord, and, finally, treatment and outcome. RESULTS: The search provided 33 papers (mainly individual case reports) and 38 patients, with a large age frame (from 12 to 70 years of age), mainly adults. Among these ones 36/38 received a pathological diagnosis and granulomatous pattern was the main reported one. The description of spinal cord involvement in MRI is variable form extensive tumefactive lesions to spinal roots prominent involvement. The mortality is high (29% at the end of the individual follow-up). DISCUSSION: As in non-spinal involvement, the main limitation of the retrieved cases is the inhomogeneity of the diagnostic and therapeutic pathway with underusing and underreporting of neuroradiolgoical techniques relevant for the diagnosis according with the available diagnostic criteria. Spinal cord involvement confirms its rarity, but it has been associated to a high disability and mortality and the diagnosis of PACNS has therapeutic consequences. CONCLUSIONS: Spinal cord involvement is present in a minority of PACNS cases with a variety of neuroradiological and pathological findings. The standardization of the diagnostic pathway could help to improve the quality of information in prospective studies.
Collapse
Affiliation(s)
- Marialuisa Zedde
- Neurology Unit, Stroke Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Via Amendola 2, Reggio Emilia, 42122, Italy.
| | - Rosario Pascarella
- Neuroradiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Via Amendola 2, Reggio Emilia, 42122, Italy
| |
Collapse
|
11
|
Fu Q, Sandeep B, Li H, Wang BS, Huang X. Impact of perioperative dexmedetomidine on postoperative delirium in adult undergoing cardiac surgery: A comprehensive bibliometrix and meta-analysis. Asian J Psychiatr 2025; 108:104522. [PMID: 40339195 DOI: 10.1016/j.ajp.2025.104522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2025] [Revised: 04/27/2025] [Accepted: 04/28/2025] [Indexed: 05/10/2025]
Abstract
This bibliometrix and meta-analysis aimed to evaluate the efficacy of perioperative dexmedetomidine (DEX) on postoperative delirium (POD) in adult patients undergoing cardiac surgery. A comprehensive search of electronic databases identified 21 randomized controlled trials involving 5210 patients. The primary outcome was the incidence of POD from the first day to seven days post-surgery. The meta-analysis revealed that DEX significantly reduced POD incidence compared to various controls (RR 0.70; 95 % CI 0.54-0.89; P = 0.004). Subgroup analyses showed that DEX was particularly effective when compared to propofol (RR 0.48; 95 % CI 0.30-0.78; P = 0.003). However, no significant differences were observed in the duration of anesthesia, surgery, or ICU/hospital stay. Notably, DEX was associated with a higher incidence of hypotension (RR 1.90; 95 % CI 1.16-3.10; P = 0.01). The study highlights the potential neuroprotective benefits of DEX but underscores the need for careful monitoring of hemodynamic stability. Future research should focus on optimizing DEX dosing protocols and exploring its broader impact on postoperative recovery and patient outcomes.
Collapse
Affiliation(s)
- Qiang Fu
- Department of Anesthesiology, The Third People's Hospital of Chengdu, Sichuan Province 610074, China
| | - Bhushan Sandeep
- Department of Cardio-Thoracic Surgery, Chengdu Second People's Hospital, Chengdu, Sichuan Province, China
| | - Hong Li
- Department of Anesthesiology, No. 363 Hospital, Chengdu, Sichuan province 610074, China.
| | - Bao San Wang
- Department of Anesthesiology, No. 363 Hospital, Chengdu, Sichuan province 610074, China.
| | - Xin Huang
- Department of Anesthesiology, The Third People's Hospital of Chengdu, Sichuan Province 610074, China.
| |
Collapse
|
12
|
Upadhyay K, Balachandar R, Bagepally BS, Ravibabu K, Dhananjayan V, Raju N, Yadav G, Ravichandran B, Das S. Estimation of the pooled mean blood lead levels of Indian children: Evidence from systematic review and meta-analysis. Toxicol Rep 2025; 14:101975. [PMID: 40104047 PMCID: PMC11914758 DOI: 10.1016/j.toxrep.2025.101975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2024] [Revised: 02/14/2025] [Accepted: 02/21/2025] [Indexed: 03/20/2025] Open
Abstract
A recent systematic review reported very high pooled estimates of blood lead levels (BLLs) for Indian children. Current study aimed at systematically pooling the BLLs of Indian children (aged ≤ 14 years). Further, explore the time trend of BLLs with respect to implementing the ban on the use of Pb-petrol (i.e.2000) and a decade later (2010). Observational studies documenting the BLL in Indian children (aged ≤ 14 years) from PubMed-Medline, Scopus, and Embase digital databases from inception to August 2024 were systematically reviewed. Detailed protocol is available at PROSPERO (ID: CRD42022382835). Pooled mean BLL was estimated using the random-effects model and conventional-I 2 statistics to assess the heterogeneity, while the Newcastle Ottawa Scale for bias assessment. Sub-group, sensitivity, and meta-regression analyses were performed where data permitted. Observations from 65 reports (51 original studies) revealed pooled BLL of 10.4 (95 % CI: 9.55-11.2) µg/dL with a trend of gradual reduction during the last 3 decades. Subgroup analysis revealed the high risk (with known Pb exposure) children had BLL of 14.3 (12.3-16.2) µg/dL, while that of the low risk (no known Pb exposure) is 8.71 (7.71-9.71) µg/dL. Only the low risk group exhibited a time trend of a gradual reduction in BLL. Notably, the review observed high heterogeneity. A progressive decline in Pb burden with respect to the national ban on leaded petrol was observed. However, present observations emphasize remedial actions toward non-occupational Pb exposure particularly among high risk Pb group, such as periodic BLL surveys.
Collapse
Affiliation(s)
- Kuldip Upadhyay
- ICMR-National Institute of Occupational Health, Ahmedabad, India
| | | | | | | | | | - Nagaraju Raju
- ICMR-NIOH-Regional Occupational Health Centre (S), Bengaluru, India
| | - Geetika Yadav
- Indian Council of Medical Research, New Delhi, India
| | | | - Santasabuj Das
- ICMR-National Institute of Occupational Health, Ahmedabad, India
| |
Collapse
|
13
|
Fukuta H, Goto T, Kamiya T. Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on hemoglobin, B-type natriuretic peptide, and renal function in anemic heart failure patients: A systematic review and meta-analysis. IJC HEART & VASCULATURE 2025; 58:101653. [PMID: 40207300 PMCID: PMC11979936 DOI: 10.1016/j.ijcha.2025.101653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2025] [Revised: 03/03/2025] [Accepted: 03/12/2025] [Indexed: 04/11/2025]
Abstract
Background Anemia is a common comorbidity in heart failure (HF) patients, often leading to worsened outcomes. Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors represent a novel approach for anemia management, yet their efficacy and safety in HF patients remain unclear. We aimed to conduct a systematic review and meta-analysis of studies on the effects of HIF-PH inhibitors on hemoglobin, N-terminal prohormone of brain natriuretic peptide (NT-proBNP), or estimated glomerular filtration rate (eGFR) in HF patients with chronic kidney disease (CKD). Methods and Results The search of electronic databases identified four studies including 98 patients. Among the included studies, two were conducted prospectively, while two were retrospective in design. No studies were identified that compared HIF-PH inhibitors with erythropoiesis-stimulating agents or placebo. In cases of significant heterogeneity (I2 > 50 %), data were pooled using a random-effects model; otherwise, a fixed-effects model was used. In pooled analyses, hemoglobin levels increased at one (weighted mean difference [WMD]: 0.697 [0.473, 0.920] g/dL; Pfix < 0.001; I2 = 24 %) and three months (WMD: 0.760 [0.443, 1.076] g/dL; Pfix < 0.001; I2 = 31 %) after the use of HIF-PH inhibitors. NT-proBNP levels showed a modest decrease at one month but no significant changes at three months. eGFR remained unchanged, and no severe adverse events were reported. Conclusion This meta-analysis suggests that HIF-PH inhibitors effectively improve anemia in HF patients with CKD without notable changes in renal or HF-related biomarkers. However, the small number of included studies and the absence of a comparator group underscore the need for cautious interpretation of the findings.
Collapse
Affiliation(s)
- Hidekatsu Fukuta
- Core Laboratory, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Toshihiko Goto
- Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Takeshi Kamiya
- Department of Medical Innovation, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| |
Collapse
|
14
|
de Moura Ferraz Barbosa MP, de Jesus NT, Bergmann A, da Silva Alves Gomes VM, Sacomori C, Dantas D. Efficacy of supervised exercise on sleep of women who survived breast cancer: a systematic review with meta-analysis. J Cancer Surviv 2025; 19:1069-1079. [PMID: 38289508 DOI: 10.1007/s11764-024-01532-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 01/07/2024] [Indexed: 05/16/2025]
Abstract
PURPOSE To analyze the efficacy of supervised exercise (SE) compared with control protocols on sleep parameters of women who survived breast cancer. METHODS This systematic review with meta-analysis searched studies using the following electronic databases: PubMed, Scopus, Physiotherapy Evidence Database (PEDro), Cochrane Library, and EMBASE. The PEDro scale assessed the bias risk, and the study protocol was registered in the PROSPERO (no. CRD42023420894). RESULTS Of 3,566 identified studies, 13 randomized clinical trials involving 847 women diagnosed with breast cancer were included. Interventions consisted of SE in an outpatient setting (62%) or combined protocols with supervised and home exercises. Most interventions (85%) used multicomponent protocols with aerobic and resistance exercises. Usual care and health education were the most reported controls. SE decreased the sleep disturbance score (- 31.61 [95% confidence interval = - 39.40 to - 23.83]) of the European Organisation for Research and Treatment of Cancer quality of life questionnaire and daytime dysfunction score (- 0.41 [95% confidence interval = - 0.73 to - 0.09]) of the Pittsburgh Sleep Quality Index (PSQI). Also, SE presented a tendency to improve the self-reported sleep quality score of the PSQI (p = 0.06). CONCLUSION SE increased the subjective sleep quality and immobility time and decreased sleep disturbance and daytime dysfunction symptoms in women who survived breast cancer. Most SE protocols were multicomponent, with aerobic and resistance exercises ranging from moderate to high intensity. IMPLICATIONS FOR CANCER SURVIVORS Supervised exercise may improve sleep quality and reduce symptoms of sleep disorders, contributing to survival outcomes.
Collapse
Affiliation(s)
| | - Naiany Tenorio de Jesus
- Department of Physical Therapy, Health Sciences Center, Federal University of Pernambuco, Recife-PE, 50740-560, Brazil
| | - Anke Bergmann
- Clinical Epidemiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil
| | | | - Cinara Sacomori
- Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago de Chile, Chile
| | - Diego Dantas
- Department of Physical Therapy, Health Sciences Center, Federal University of Pernambuco, Recife-PE, 50740-560, Brazil.
| |
Collapse
|
15
|
Ditonno F, Pettenuzzo G, Montanaro F, De Bon L, Costantino S, Toska E, Malandra S, Cianflone F, Bianchi A, Porcaro AB, Cerruto MA, Veccia A, Bertolo R, Antonelli A. Head-to-head comparison of DaVinci and Hugo™ RAS robotic platforms for robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies. Prostate Cancer Prostatic Dis 2025; 28:309-317. [PMID: 39402370 DOI: 10.1038/s41391-024-00908-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Revised: 10/02/2024] [Accepted: 10/07/2024] [Indexed: 05/28/2025]
Abstract
BACKGROUND We conducted a systematic review and meta-analysis of comparative studies to analyze intra- and postoperative outcomes of robot-assisted radical prostatectomy (RARP) using either DaVinci (DV-RARP) or Hugo™RAS (H-RARP) platforms. METHODS The study was registered in PROSPERO (CRD42024562326) and followed PRISMA guidelines. Literature search was conducted in June 2024 using academic databases, focusing on articles from 2021 to 2024. Research question focused on men with PCa (P) undergoing H-RARP (I) versus DV-RARP (C) to evaluate surgical, pathology, and functional outcomes (O), across comparative studies. Continuous variables were summarized using mean difference (MD) and categorical variables using odds ratio with 95% confidence intervals (CI). Heterogeneity was assessed using Cochran's Q test and I2 statistics. Publication bias was evaluated with Egger's and Begg's tests. Statistical analysis was performed with Stata®17.0, with significance set at p < 0.05. Risk of bias was assessed using the ROBINS-I tool. Methodological quality was evaluated with AMSTAR 2. RESULTS Eight studies (three prospective, five retrospective) with 1114 patients (454 H-RARP vs. 660 DV-RARP) were included. Baseline characteristics were comparable between groups. No significant differences were found in overall operative time, console time, blood loss, nerve-sparing, or lymphadenectomy. Docking time was significantly longer for Hugo™RAS (MD:6 min,95% CI 4.2;7.8). Postoperative outcomes, including complications, length of stay, and catheterization time, were similar. Pathological outcomes showed no significant differences in positive surgical margins or staging, but lower node yield was observed with H-RARP (MD:-2,95% CI -3.3;-0.6). Urinary continence recovery was comparable. Risk of bias was moderate to serious. CONCLUSION The meta-analysis suggests H-RARP and DV-RARP perform not statistically different across most of analyzed outcomes, except for docking time and lymph-node yield. The longer docking time associated with the Hugo™RAS suggests demanding setup but does not translate into significantly longer operative time. Although statistically significant, the observed difference in lymph-node yield might be clinically negligible.
Collapse
Affiliation(s)
- Francesco Ditonno
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Greta Pettenuzzo
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Francesca Montanaro
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Lorenzo De Bon
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Sonia Costantino
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Endri Toska
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Sarah Malandra
- Residency Program in Health Statistics and Biometrics, University of Verona, Verona, Italy
| | - Francesco Cianflone
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Alberto Bianchi
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Antonio Benito Porcaro
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Maria Angela Cerruto
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Alessandro Veccia
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| | - Riccardo Bertolo
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy.
| | - Alessandro Antonelli
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy
| |
Collapse
|
16
|
Fernández Alonso AM, Varikasuvu SR, Pérez-López FR. Telomere length and telomerase activity in men and non-pregnant women with and without metabolic syndrome: a systematic review and bootstrapped meta-analysis. J Diabetes Metab Disord 2025; 24:24. [PMID: 39735175 PMCID: PMC11671447 DOI: 10.1007/s40200-024-01513-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Accepted: 11/19/2024] [Indexed: 12/31/2024]
Abstract
Purpose We performed a systematic review and meta-analysis to examine the associations between telomere length and telomerase activity in subjects with and without metabolic syndrome (MetS). Methods The meta-analysis protocol was registered in the PROSPERO database. The PubMed, Embase, Cochrane Library, and LILACS databases were searched for studies reporting telomere length or telomerase activity in adult men and non-pregnant women with and without MetS. The risk of bias was assessed with the Newcastle-Ottawa Scale. Random effects and inverse variance methods were used to meta-analyze associations. We conducted a bootstrapped analysis to test the accuracy of clinical results. Results Five studies reported telomere length and two studies telomerase activity. There was no significant difference in telomere length (standardized mean difference [SMD]: 0.10, 95% confidence interval [CI]: -0.07, 0.28, I 2: 54%), between subjects of similar age (mean difference: 2.68, 95%CI: -0.04, 5.40 years) with and without the MetS. Subjects with MetS displayed significantly higher body mass index, triglycerides, and blood pressure, and lower HDL-cholesterol values than subjects without the syndrome. A bootstrapping mediation analysis of telomere length confirmed the clinical results. There was no significant difference in telomerase activity (SMD: 1.19, 95% CI -0.17, 2.55, I 2: 93%) between subjects with and without the MetS. Conclusion There were no significant differences of telomere length and telomerase activity in patients with MetS and subjects of similar age without the syndrome. Supplementary Information The online version contains supplementary material available at 10.1007/s40200-024-01513-4.
Collapse
Affiliation(s)
- Ana Maria Fernández Alonso
- Department of Obstetrics and Gynecology, Torrecárdenas University Hospital, Almería, Paraje Torrecárdenas s/n 04009 Spain
| | | | - Faustino R. Pérez-López
- Aragón Health Research Institute, University of Zaragoza Faculty of Medicine, Domingo Miral s/n, Zaragoza, 50009 Spain
| |
Collapse
|
17
|
Li J, Wang X, Wu J, Geng D, Li F, Liu Y, Shen Y. Efficacy and safety of iGlarLixi versus insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials. Endocrine 2025; 88:731-738. [PMID: 40011373 DOI: 10.1007/s12020-025-04207-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Accepted: 02/20/2025] [Indexed: 02/28/2025]
Abstract
OBJECTIVE This meta-analysis aimed to compare the efficacy and safety of iGlarLixi with those of insulin glargine for treating type 2 diabetes (T2D). METHODS A systematic search of PubMed, the Cochrane Library, and EMBASE was conducted to identify randomized controlled trials (RCTs) that compared the use of iGlarLixi with the use of insulin glargine in patients with T2D. The meta-analysis protocol was registered at PROSPERO. The primary outcomes of interest were changes in hemoglobin A1c (HbA1c) and body weight. Risk ratios and mean differences with 95% confidence intervals were calculated using random-effects models. RESULTS We included 7 RCTs comprising 2229 men and 1926 women, of whom 2075 (49.94%) were randomized to iGlarLixi. Compared with insulin glargine, iGlarLixi decreased HbA1c (MD: -0.50%; 95% CI: -0.65% to -0.35%; p < 0.00001) and body weight (MD: -1.17 kg; 95% CI: -1.36 kg to -0.98 kg; p < 0.00001) and self-measured plasma glucose (MD: -0.97 mmol/L; 95% CI: -1.27 mmol/L to -0.68 mmol/L; p < 0.00001) and increased the percentage of patients achieving HbA1c < 7% (RR: 1.66; 95% CI: 1.31 to 2.11; p < 0.0001), the percentage of patients achieving HbA1c < 6.5% (RR: 2.11; 95% CI: 1.53 to 2.92; p < 0.00001), and HbA1c < 7.0% without weight gain and/or without severe or blood glucose-confirmed hypoglycemic episodes (RR: 2.18; 95% CI: 1.76 to 2.69; p < 0.00001). However, a higher incidence of gastrointestinal adverse events (RR: 2.02; 95% CI: 1.61 to 2.54; p < 0.00001) and adverse events (RR: 1.08; 95% CI: 1.02 to 1.14; p = 0.008) was associated with iGlarLixi than with insulin glargine. CONCLUSIONS Compared with insulin glargine, iGlarLixi is superior in reducing blood glucose levels and facilitating weight loss. Nevertheless, its administration is also linked to a heightened occurrence of gastrointestinal and adverse events.
Collapse
Affiliation(s)
- Jingxin Li
- Department of Pharmacy, Hebei Chest Hospital, Shijiazhuang, China
| | - Xiaomin Wang
- Department of Pharmacy, Hebei Chest Hospital, Shijiazhuang, China
| | - Jingcheng Wu
- Department of Pharmacy, Hebei Chest Hospital, Shijiazhuang, China
| | - Dandan Geng
- Department of Pharmacy, Hebei Chest Hospital, Shijiazhuang, China
| | - Fan Li
- Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, China
| | - Yang Liu
- Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, China
| | - Yanhong Shen
- Department of Pharmacy, Hebei Chest Hospital, Shijiazhuang, China.
| |
Collapse
|
18
|
Stolwijk PJ, Verweij LPE, Kerkhoffs GMMJ, van Deurzen DFP, Priester-Vink S, Sierevelt IN, van den Bekerom MPJ. Patient-Reported Outcome Measures Show No Relevant Change Between 1-Year and 2-Year Follow-Up After Treatment for Anterior Shoulder Instability: A Systematic Review. Arthroscopy 2025; 41:2090-2102.e9. [PMID: 39243995 DOI: 10.1016/j.arthro.2024.08.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 08/20/2024] [Accepted: 08/20/2024] [Indexed: 09/09/2024]
Abstract
PURPOSE To compare patient-reported outcome measures (PROMs) at 1-year and 2-year follow-up after treatment for anterior shoulder instability. METHODS Randomized controlled trials and prospective studies that evaluated and reported PROMs after a capsulolabral repair (with or without remplissage), bone augmentation, or nonoperative treatment to treat anterior shoulder instability at both 1-year and 2-year follow-up were included. PROMs were compared between 1-year and 2-year follow-up; forest plots with mean difference were created to compare baseline, 1-year, and 2-year follow-up; and scatterplots were created to visualize clinical improvement over time. RESULTS Fourteen studies, comprising 923 patients, with levels of evidence Level I and II were included. Nine PROMs, of which predominantly were the Western Ontario Shoulder Instability Index (WOSI; 11 studies; 79%), were evaluated. Minimal to no statistically significant change in WOSI, Oxford Shoulder Instability Score, American Shoulder and Elbow Surgeons (ASES), Subjective Shoulder Value, Simple Shoulder Test, Disabilities of Arm, Shoulder, and Hand (DASH), Quick DASH, Single Assessment Numeric Evaluation, or visual analog scale was observed between 1-year and 2-year follow-up. Pooling of the WOSI, Oxford Shoulder Instability Score, ASES, and Single Assessment Numeric Evaluation demonstrated improvement from baseline to 1-year follow-up and minimal to no change between 1-year and 2-year follow-up. Scatterplots of the WOSI and ASES demonstrated the most improvement within 6 months and no clear improvement after 1-year follow-up. Recurrence rates increased with time but varied between studies. CONCLUSIONS In contrast to recurrence rates, which have been shown to increase with time, minimal to no statistically significant change was observed for any of the included PROMs between 1-year and 2-year follow-up. This finding raises the question as to whether it is necessary to evaluate PROMs in long-term follow-up of patients after shoulder stabilization treatment. LEVEL OF EVIDENCE Level II, systematic review of Level I and II studies.
Collapse
Affiliation(s)
- Paul J Stolwijk
- Department of Orthopedic Surgery and Sports Medicine, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
| | - Lukas P E Verweij
- Department of Orthopedic Surgery and Sports Medicine, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Movement Sciences, Musculoskeletal Health Program, Amsterdam, The Netherlands; Amsterdam Shoulder and Elbow Centre of Expertise (ASECE), Amsterdam, The Netherlands
| | - Gino M M J Kerkhoffs
- Department of Orthopedic Surgery and Sports Medicine, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Movement Sciences, Musculoskeletal Health Program, Amsterdam, The Netherlands
| | - Derek F P van Deurzen
- Amsterdam Shoulder and Elbow Centre of Expertise (ASECE), Amsterdam, The Netherlands; Department of Orthopedic Surgery, Shoulder and Elbow unit, OLVG, Amsterdam, The Netherlands
| | | | - Inger N Sierevelt
- Xpert Clinics, Department of Orthopedic Surgery, Amsterdam, The Netherlands; Spaarnegasthuis Academy, Orthopedic Department, Hoofddorp, The Netherlands
| | - Michel P J van den Bekerom
- Amsterdam Shoulder and Elbow Centre of Expertise (ASECE), Amsterdam, The Netherlands; Department of Orthopedic Surgery, Shoulder and Elbow unit, OLVG, Amsterdam, The Netherlands; Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, the Netherlands
| |
Collapse
|
19
|
Daghmouri MA, Chaouch MA, Noomen M, Chaabene W, Deniau B, Barnes E, Mion G, Cheurfa C, Gafsi B, Camby M. Etomidate versus ketamine for in-hospital rapid sequence intubation: a systematic review and meta-analysis. Eur J Emerg Med 2025; 32:160-170. [PMID: 40239104 DOI: 10.1097/mej.0000000000001237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/18/2025]
Abstract
Rapid sequence intubation (RSI) is a critical procedure in emergency and intensive care settings. Etomidate has been favored for its hemodynamic stability; however, concerns about adrenal insufficiency have prompted interest in ketamine as an alternative induction agent. This systematic review and meta-analysis aimed to compare the effects of etomidate vs ketamine on 30-day survival and other clinical outcomes in critically ill patients undergoing in-hospital RSI. A comprehensive literature search was conducted until 1 November 2024, across PubMed, Embase, Web of Science, Cochrane databases, and clinical trial registries. Eligible studies included randomized controlled trials (RCTs) and controlled clinical trials (CCTs) assessing etomidate vs ketamine for RSI. The primary outcome was 30-day survival. Secondary outcomes encompassed intubation difficulty, post-intubation vasopressor use, cardiovascular collapse, Sequential Organ Failure Assessment score, systemic steroid use, organ support-free days, and adrenal insufficiency. Fourteen studies comprising 23 926 patients (19 288 receiving etomidate; 4638 receiving ketamine) met the inclusion criteria. Pooled analyses of RCTs and CCTs revealed no significant difference in 30-day survival between the two agents [RCTs: odds ratio (OR) = 0.92, 95% confidence interval (CI): 0.68-1.24, P = 0.58; CCTs: OR = 1.16, 95% CI: 0.92-1.45, P = 0.58]. Ketamine was associated with a higher requirement for post-intubation vasopressor support (OR = 0.71, 95% CI: 0.53-0.96, P = 0.03) and an increase in ICU-free days. Etomidate use correlated with a significantly higher incidence of adrenal insufficiency (OR = 2.43, 95% CI: 1.67-3.53, P < 0.001). No significant differences were observed in intubation difficulty, cardiovascular collapse, or systemic steroid use between the groups. Ketamine and etomidate showed no significant difference in 30-day survival among critically ill patients undergoing RSI. However, etomidate was associated with a higher incidence of adrenal insufficiency, while ketamine required more post-intubation vasopressor support. Provenance and peer review: Not commissioned, externally peer-reviewed.
Collapse
Affiliation(s)
- Mohamed Aziz Daghmouri
- Department of Anesthesia, Center for Intercommunal Hospitals of Montreuil, Montreuil, France
| | | | - Mohamed Noomen
- Department of Anesthesiology, Monastir University Hospital, Monastir, Tunisia
| | - Wael Chaabene
- Department of Emergency, Perpignan Hospital, Perpignan
| | - Benjamin Deniau
- Department of Anesthesiology, Critical Care and Burn Unit, University Hospital Saint-Louis-Lariboisière, AP-HP
- INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration
| | - Ellington Barnes
- Department of Anesthesia, Center for Intercommunal Hospitals of Montreuil, Montreuil, France
| | - Georges Mion
- Department of Anesthesia, Cochin University Hospital
| | - Cherifa Cheurfa
- Department of Anesthesiology and Critical Care Medicine, Cochin University Hospital, Paris Cité University, Assistance Publique-Hôpitaux de Paris
- Center for Research in Epidemiology and Statistics (CRESS), Université Paris Cité, Inserm, INRAE, Paris, France
| | - Besma Gafsi
- Department of Anesthesiology, Monastir University Hospital, Monastir, Tunisia
| | - Matthieu Camby
- Department of Anesthesia, Center for Intercommunal Hospitals of Montreuil, Montreuil, France
| |
Collapse
|
20
|
Theodorakopoulou MP, Sgouropoulou V, Iatridi F, Karagiannidis AG, Karpetas A, Sampani E, Anyfanti P, Dimitroulas T, Sarafidis P. Vascular endothelial dysfunction in pediatric rheumatic diseases: a systematic review and meta-analysis. Expert Rev Clin Immunol 2025:1-11. [PMID: 40415239 DOI: 10.1080/1744666x.2025.2510490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2025] [Accepted: 05/14/2025] [Indexed: 05/27/2025]
Abstract
OBJECTIVES Endothelial dysfunction is associated with increased cardiovascular risk in individuals with autoimmune diseases. This systematic review and meta-analysis included studies assessing endothelial function with functional methods in children with rheumatic diseases versus controls. METHODS Literature search involved PubMed and Scopus databases (from inception to February 2024) and manual reference screening. Studies assessing endothelial function by all available functional methods were eligible. Study quality was evaluated via Newcastle-Ottawa scale. RESULTS Twenty-four studies (880 children with rheumatic diseases, 784 controls) were included in meta-analysis. Pooled analysis showed significantly impaired endothelial function in patients versus controls (SMD: -0.74, 95%CI -1.10 to -0.39) but with high heterogeneity (I2 = 91%, p < 0.001); sensitivity analysis including only high-quality studies confirmed this finding (SMD: -0.83, 95%CI -1.20 to -0.46). In subgroup analyses according to type of rheumatic disease, significantly impaired endothelial function was showed for patients with juvenile idiopathic arthritis (SMD: -1.05, 95%CI -1.84 to -0.25), vasculitis (SMD: -0.74, 95%CI -1.11 to -0.37) and juvenile systemic sclerosis (SMD -2.48, 95%CI -4.34 to -0.61). CONCLUSIONS Children with rheumatic diseases show impaired endothelial function. Future studies are needed to elucidate whether endothelial dysfunction is involved in high cardiovascular risk of these patients. PROSPERO REGISTRATION NUMBER CRD42023413799.
Collapse
Affiliation(s)
| | - Vasiliki Sgouropoulou
- 1st Department of Paediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Fotini Iatridi
- 1st Department of Nephrology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | | | | | - Erasmia Sampani
- 1st Department of Nephrology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Panagiota Anyfanti
- 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Theodoros Dimitroulas
- 4th Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Pantelis Sarafidis
- 1st Department of Nephrology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
21
|
Mainville L, Xu L, Piguet V, Drucker AM, Croitoru DO. Time to Disease Control with Dupilumab for Bullous Pemphigoid: A Systematic Review and Meta-analysis. Acta Derm Venereol 2025; 105:adv43667. [PMID: 40423583 DOI: 10.2340/actadv.v105.43667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2025] [Accepted: 05/13/2025] [Indexed: 05/28/2025] Open
Abstract
Bullous pemphigoid (BP) is a chronic autoimmune blistering disease primarily affecting the elderly population. While awaiting the results from randomized clinical trials to assess the effect of dupilumab in patients with BP, clinicians have begun to introduce dupilumab into their therapeutic arsenal, with few data supporting their clinical decisions. The objectives were to assess time to disease control, predictors of response, achievement of disease control, disease recurrence, and occurrence of adverse events. Randomized and non-randomized studies of interventions (NRSIs) from Medline and Embase were reviewed. A total of 315 studies were identified and 5 NRSIs (167 participants with moderate-to-severe BP) meeting our inclusion criteria were found. Dupilumab was significantly associated with shorter time to disease control compared with the control group (HR 2.71 [95% CI, 1.85-3.96; I2 = 35%; 127 participants; 4 studies]). The overall strength of the evidence was graded as very low due to serious risk of bias and imprecision of effect measures. There were insufficient data to inform conclusions regarding BP recurrence and adverse events. Evidence was found that dupilumab reduces time to disease control in BP. It was not possible to assess predictors of response using pre-planned meta-regression. Randomized controlled trials are needed to determine dupilumab's place in therapeutic algorithms for BP. PROSPERO number: CRD42024599235.
Collapse
Affiliation(s)
- Laurence Mainville
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, ON, Canada; Division of Dermatology, Department of Medicine, CHU de Québec-Université Laval, Québec, QC, Canada.
| | | | - Vincent Piguet
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, ON, Canada
| | - Aaron M Drucker
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, ON, Canada
| | - David O Croitoru
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, ON, Canada;Division of Dermatology, Department of Medicine, University Health Network, Toronto, Ontario, Canada
| |
Collapse
|
22
|
Jamialahamdi T, Mirhadi E, Almahmeed W, Virani S, Eid AH, Al-Rasadi K, Salehabadi S, Sahebkar A. Impact of Semaglutide Administration on Weight Loss After Bariatric Surgery: A Meta-Analysis. Obes Surg 2025:10.1007/s11695-025-07848-y. [PMID: 40418526 DOI: 10.1007/s11695-025-07848-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2025] [Revised: 02/13/2025] [Accepted: 03/31/2025] [Indexed: 05/27/2025]
Abstract
BACKGROUND A significant number of patients encounter weight gain (WG) or inadequate weight loss (IWL) following bariatric surgery for obesity. Recent studies have explored the role of semaglutide in addressing weight management challenges in patients who have inadequate weight loss or weight gain after bariatric surgery. Despite such studies, a systematic review and meta-analysis evaluating the efficacy, safety and tolerability of semaglutide in this specific clinical context remains absent. Therefore, this study was undertaken to address this knowledge gap. METHODS Databases were searched for randomized controlled trials (RCTs), case-control, cohort and observational studies involving use of semaglutide in the intervention arm post-bariatric surgery. Outcome was weight loss post-bariatric surgery. RESULTS A total of six studies (300 participants) demonstrated significant weight reduction following semaglutide administration after bariatric surgery (WMD: - 15.730, 95% CI: - 22.140, - 9.320, p < 0.001). This effect remained robust in sensitivity analysis. CONCLUSION The current data encourages the use of semaglutide for managing WG or IWL post-bariatric surgery.
Collapse
Affiliation(s)
- Tannaz Jamialahamdi
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Elaheh Mirhadi
- School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Wael Almahmeed
- Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
| | | | - Ali H Eid
- Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar
| | - Khalid Al-Rasadi
- Medical Research Centre, Sultan Qaboos University, Muscat, Oman
- Department of Biochemistry, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman
| | - Sepideh Salehabadi
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Amirhossein Sahebkar
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Centre for Research Impact and Outcome, Chitkara University, Rajpura, 140417, Punjab, India.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
| |
Collapse
|
23
|
Eltyeb HA, Mohamedahmed AYY, Mills GA, Khan J. Left colectomy for diverticular disease: systematic review and meta-analysis comparing robotic and laparoscopic resections. Tech Coloproctol 2025; 29:121. [PMID: 40413682 DOI: 10.1007/s10151-025-03155-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/18/2024] [Accepted: 04/05/2025] [Indexed: 05/27/2025]
Abstract
BACKGROUND Around 50% of people aged 60 years and above are affected by diverticular disease, and 25% of these individuals will require surgical intervention. Our objective is to compare the results of left colonic resection for sigmoid diverticular disease using both robotic and laparoscopic approaches. Our primary aim is to conduct a meta-analysis while investigating the rates of conversion to open surgery, stoma and complications between the two methods. METHODOLOGY A systematic review was conducted following the PRISMA guidelines. A meta-analysis was performed using RevMan Version 5.4 software. The random-effect model was employed to pool dichotomous outcomes and estimate risk and odds ratios (OR). RESULTS Eight studies were thought to fulfil the eligibility criteria: 1892 patients (49.2%) had robotic surgery, and 1952 patients (50.84%) underwent a laparoscopic approach. There were fewer conversions to open surgery in the robotic group when compared to the laparoscopic group (P < 0.00001), a lower rate of postoperative ileus (P = 0.005), shorter length of stay (mean difference (MD) 0.18 P = 0.003) and fewer morbidities (P = 0.002). There were similar rates of stoma formation (4.7%, P = 1.00), anastomotic leak (2.6%, P = 0.85) and mortality (0.3% vs 0.2%, P = 0.59). The operative time was shorter in the robotic approach, although the difference was not significant (P = 0.47). CONCLUSION Robotic surgery is feasible for diverticular disease compared to laparoscopic left colectomy. Our study observed a reduction in the conversion to open rate, reduced morbidity, and less ileus while demonstrating similar rates of stoma formation, anastomotic leak, and mortality. However, more high-quality research needs to be conducted to investigate this further. The study is registered in Prospero (reg # CRD42023440509).
Collapse
Affiliation(s)
- H A Eltyeb
- Department of General Surgery, Queen Elizabeth Hospital, Queen Elizabeth Ave, Gateshead, NE9 6SX, UK.
- Faculty of Science, University of Portsmouth, St Michael's Building, Portsmouth, PO1 2DT, UK.
| | - A Y Y Mohamedahmed
- University Hospitals of Derby and Burton, Uttoxeter Road Derby Derbyshire, Burton on Trent, DE22 3NE, UK
| | - G A Mills
- Faculty of Science, University of Portsmouth, St Michael's Building, Portsmouth, PO1 2DT, UK
| | - J Khan
- Faculty of Science, University of Portsmouth, St Michael's Building, Portsmouth, PO1 2DT, UK
- Portsmouth Hospitals University NHS Trust, Southwick Hill Road Cosham, Portsmouth, PO6 3LY, UK
| |
Collapse
|
24
|
Bonavina G, Bonitta G, Aiolfi A, Salmeri N, Candiani M, Cavoretto PI, Bonavina L, Bulfoni A, PPH working group members. Every minute counts: a network meta-analysis comparing the effect of prophylactic endovascular procedures in abnormal placentation. World J Emerg Surg 2025; 20:43. [PMID: 40413552 PMCID: PMC12102999 DOI: 10.1186/s13017-025-00602-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Collaborators] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2025] [Accepted: 03/22/2025] [Indexed: 06/12/2025] Open
Abstract
BACKGROUND Preventing postpartum haemorrhage remains a high priority worldwide. We aimed to provide all available evidence comparing maternal and neonatal outcomes of different prophylactic endovascular procedures in patients with abnormal placentation. METHODS Pubmed, Embase and ClinicalTrials.gov databases were searched from inception to Nov, 2024, using relevant key words. Studies comparing outcomes of women undergoing or not prophylactic endovascular procedures in planned cesarean delivery in patients with antenatally suspected or confirmed PAS, placenta previa or both were included. An arm-based random effect frequentist network meta-analysis was performed. All available maternal and neonatal outcomes were evaluated. RESULTS Three randomized controlled trials and 59 observational studies were eligible reporting on 6973 women (42.9% did not undergo any endovascular procedure, 26.7% underwent aortic balloon occlusion, REBOA, 16.6%, internal iliac balloon occlusion, PBO-IIA, 5.8%, common iliac artery occlusion, PBO-CIA, placement, and 7.8% underwent uterine artery embolization, UAE). The pooled network analysis showed that all prophylactic endovascular procedures were associated with reduced perioperative blood loss, with proximal balloon occlusion (REBOA) having the strongest effect (SMD -1.80 L, 95%CI -2.38;-1.21; I2 = 97.2%). Also, peripartum hysterectomy rates were significantly lower in women undergoing prophylactic UAE and REBOA compared to the control group; moreover, patients with placenta previa without any prophylactic endovascular procedure had a 4 to fivefold increased risk of peripartum hysterectomy compared to the REBOA group (I2 = 20.6%). REBOA was associated with a significant decrease in massive transfusion rates (I2 = 0%), surgery-related complications (I2 = 0%), ICU admissions (I2 = 40.3%), and units of red blood cells transfused (I2 = 92.8%), compared to PBO-IIA and control groups. The control group versus women undergoing prophylactic UAE showed a significant increase in total operative time (I2 = 96.5%) and Clavien-Dindo grade IV post-operative complications (I2 = 26%), compared to REBOA. All prophylactic endovascular procedures had a comparable risk ratio in terms of units of platelets transfused, maternal mortality, and use of additional post-operative bilateral uterine artery embolization among the treatment groups. As for neonatal outcomes, no significant differences were detected. CONCLUSIONS Although the preponderance of observational studies suggests caution in interpreting the results of this meta-analysis, our findings suggest that prophylactic endovascular interventional procedures, particularly aortic balloon occlusion, may substantially improve clinical outcomes in women with PAS, placenta previa or both. PROSPERO REGISTRATION NUMBER CRD4202457398.
Collapse
Affiliation(s)
- Giulia Bonavina
- Department of Obstetrics and Gynecology, IRCCS Multimedica, Milan, Italy.
| | - Gianluca Bonitta
- Department of Obstetrics and Gynecology, IRCCS Multimedica, Milan, Italy
| | - Alberto Aiolfi
- IRCCS Ospedale Galeazzi - Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Milan, Italy
| | - Noemi Salmeri
- Department of Clinical Sciences and Community Health, Università degli Studi, Milan, Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Massimo Candiani
- Department of Obstetrics and Gynaecology, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy
| | - Paolo Ivo Cavoretto
- Department of Obstetrics and Gynaecology, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy
| | - Luigi Bonavina
- IRCCS Policlinico San Donato, Division of General and Foregut Surgery, Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
| | - Alessandro Bulfoni
- Department of Obstetrics and Gynecology, IRCCS Multimedica, Milan, Italy
| | | |
Collapse
Collaborators
Stefano Acerboni, Claudio Anza', Federico Coccolini, Francesco De Cobelli, Giulia Dal Vecchio, Laura Di Marco, Giuditta Ferrara, Enrico Iurlaro, Randa Kaltoud, Cecilia Marino, Marta Ruggiero, Nicola Uderzo, Paolo Taccone,
Collapse
|
25
|
Khosravaninezhad Y, Moshfeghinia R, Liaghat L, Ghazipoor H, Kaheni Y, Javidan A, Mirzaee Y, Azadmehr A, Hashemi Y, Pasalar M. Effect of acupressure and acupuncture on sleep quality in cancer patients with insomnia: A systematic review and meta-analysis. Explore (NY) 2025; 21:103192. [PMID: 40449465 DOI: 10.1016/j.explore.2025.103192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2024] [Revised: 02/04/2025] [Accepted: 05/19/2025] [Indexed: 06/03/2025]
Abstract
INTRODUCTION Cancer patients frequently experience insomnia, adversely affecting their quality of life. This study aimed to systematically review and analyse the effectiveness and safety of acupressure and acupuncture in improving sleep quality among cancer patients suffering from insomnia, providing evidence for non-pharmacological treatment options. METHODS Several digital databases (Scopus, PubMed, Embase, Web of Science, Medline, Cochrane library, PsycINFO, CINAHL complete, and Google Scholar) were examined for English-language records. Inclusion criteria involved randomized controlled trials assessing the impact of acupressure or acupuncture on cancer patients with insomnia. The Cochrane Collaboration's instrument was employed to evaluate the quality of the encompassed studies. For meta-analysis, a model that accounts for variability among studies was favoured, and statistical analysis was conducted using Stata software version 17. RESULTS This review analysed 13 randomized controlled trials involving 806 cancer patients. The analysis indicated that sleep quality didn't differ significantly between treatment and control groups. However, sleep efficacy was significantly higher in the treatment group (SMD [95 % CI] = 0.43 [0.21, 0.65]). Additionally, total sleep time showed a significantly higher extent in the treatment group (SMD [95 % CI] = 0.58 [0.24, 0.92]). No significant differences were found for depression or sleep onset latency between groups, while anxiety levels were lower in the treatment group (SMD [95 % CI] = -0.52 [-0.90, -0.15]). CONCLUSION The review suggests that acupressure and acupuncture enhance sleep quality in cancer patients suffering from insomnia, showing notable benefits during follow-up, especially among Asian participants.
Collapse
Affiliation(s)
- Yasamin Khosravaninezhad
- Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Reza Moshfeghinia
- Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran; Substance Abuse Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Leila Liaghat
- Department of Family Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hamid Ghazipoor
- Department of Family Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Yasamin Kaheni
- Innovative Medical Research Center, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran
| | - Amin Javidan
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Yeganeh Mirzaee
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Adib Azadmehr
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Yussef Hashemi
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mehdi Pasalar
- Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
26
|
Hohmann E, Keough N, Stokes D, Frank R, Rodeo S. Adipose- and bone marrow-derived stromal cells reduce pain in patients with knee osteoarthritis but do not substantially improve knee functionality: an updated systematic review and meta-analysis. EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY & TRAUMATOLOGY : ORTHOPEDIE TRAUMATOLOGIE 2025; 35:214. [PMID: 40407910 PMCID: PMC12102120 DOI: 10.1007/s00590-025-04322-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/26/2024] [Accepted: 04/25/2025] [Indexed: 05/26/2025]
Abstract
PURPOSE To perform a systematic review and meta-analysis of randomized and comparative studies comparing mesenchymal stromal cells other orthobiological injections for patients with knee osteoarthritis. METHODS Systematic review of Medline, Embase, Scopus, and Google Scholar, including all level 1-3 from 2014 to 2024. Validated scores (VAS, KOOS, Lysholm, IKDC) were included as outcome measures. Risk of bias was assessed using the Cochrane Collaboration's tools. The GRADE system was used to assess the quality of the body of evidence and the modified Coleman Methodology score was used to assess study quality. Heterogeneity was assessed using χ2 and I2 statistics. RESULTS Ten studies were included; all published in English between 2019 and 2023, encompassing a total of 563 cases (281 treated with MSCs and 282 with other biologics). Two studies had a high risk of bias, one had some bias, and seven had a low risk of bias. Publication bias was detected (Egger's test 3.26447; p = 0.007). The pooled estimates revealed significant differences favoring MSCs for VAS scores at 3, 6, and 12 months. For KOOS pain and symptoms, significant differences were observed at 3 and 6 months. CONCLUSION The results of this meta-analysis demonstrated a significant effect of adipose and bone marrow-derived stromal cell injections on pain reduction at all assessed time points, and showed superiority over other non-surgical treatment options. These differences were not reflected in clinical and functional outcomes, indicating that the observed reduction in pain did not correspond to substantial improvements in knee functionality.
Collapse
Affiliation(s)
- Erik Hohmann
- Medical School, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
| | | | | | | | | |
Collapse
|
27
|
Onishi FJ, de Vasconcelos VT. ALIF vs. posterior fusion for lumbar degenerative disease: comparable efficacy but elevated risk of severe complications-a systematic review and meta-analysis. EUROPEAN SPINE JOURNAL : OFFICIAL PUBLICATION OF THE EUROPEAN SPINE SOCIETY, THE EUROPEAN SPINAL DEFORMITY SOCIETY, AND THE EUROPEAN SECTION OF THE CERVICAL SPINE RESEARCH SOCIETY 2025:10.1007/s00586-025-08914-w. [PMID: 40402235 DOI: 10.1007/s00586-025-08914-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/22/2024] [Revised: 03/18/2025] [Accepted: 05/01/2025] [Indexed: 05/23/2025]
Abstract
BACKGROUND Over the past years, there has been an upward trend in the total number of spinal fusion procedures worldwide. There are many different strategies to perform the lumbar fusion, each with some advantages. Hospital charges for lumbar spinal surgeries also have increased significantly, with great variation in the costs and recommendations of different surgical procedures. There has also been a trend increase in the rate of the use of interbody fusion implants compared to that of traditional decompression surgery, even though the former is known to incur higher costs. Access through the anterior route gained many followers after studies on sagittal balance, and its indication has also increased worldwide. However, this technique presents different patterns of complications from those observed in traditional posterior approaches. OBJECTIVES This study aims to determine the safety and efficacy of surgery in managing patients with symptomatic lumbar degenerative diseases by comparing the effectiveness of posterior and anterior approach techniques to treat this condition on patient-related outcomes. We also aimed to investigate the safety of these surgical interventions by including perioperative complication data. METHODS A systematic search of multiple online databases was conducted up to August 2024 to identify randomized controlled trials (RCTs) and other high-quality retrospective studies comparing outcomes of anterior lumbar interbody fusion (ALIF) versus posterior fusion techniques (PLF, PLIF, TLIF) in the treatment of degenerative lumbar diseases. The primary outcomes assessed included the Oswestry Disability Index, Visual Analogue Scale, and overall clinical improvement. Secondary outcomes encompassed complications such as mortality, infections, gastrointestinal complications, deep vein thrombosis (DVT), surgical site infections, and the need for blood transfusions, as well as length of hospital stay and operative duration. Pooled effect estimates were calculated and presented as mean differences (MD) with 95% confidence intervals (CI) at the two-year follow-up. RESULTS Regarding VAS and ODI, anterior and posterior approaches were similar in analyzing five RCTs. Including retrospective studies, we also found that the length of hospital stay and duration of surgery were comparable between the two approaches. Anterior approaches had a lower rate of patients requiring blood transfusions OR 0,69[0.60,0,80]. Anterior approaches showed higher rates of mortality (0,21%) OR1,33[1.10,1.62], deep vein thrombosis (0,65%) 1.73 [1.35, 2.20], and gastrointestinal complications (4,9%) OR 2.19 [1.73, 2.78]. CONCLUSION Clinical outcomes measured by VAS and ODI were comparable between anterior and posterior approaches, demonstrating similar efficacy in treating lumbar degenerative diseases. However, the safety profiles varied significantly. Anterior approaches carried higher rates of severe complications, including mortality, DVT, and gastrointestinal events, while posterior techniques were linked to increased blood transfusion needs. Given the elevated risk of severe complications with ALIF, posterior approaches should be prioritized as the first-line option for lumbar degenerative disease.
Collapse
|
28
|
Zare A, Zare A, Hajikarimloo B, Mohammadi B, Sheehan JP, Iranmehr A. Radiosurgery for central nervous system ependymomas: a systematic review and meta-analysis. J Neurooncol 2025:10.1007/s11060-025-05076-z. [PMID: 40397320 DOI: 10.1007/s11060-025-05076-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2025] [Accepted: 05/06/2025] [Indexed: 05/22/2025]
Abstract
BACKGROUND Ependymomas, rare malignant central nervous system (CNS) lesions (2-6% of primary CNS tumors), are typically treated with maximal safe resection followed by fractionated radiation therapy. Stereotactic radiosurgery (SRS) has emerged as an alternative, particularly in recurrent or residual cases. This study evaluates the safety and efficacy of SRS for CNS ependymomas, while also identifying key prognostic factors. METHOD A systematic search was conducted to identify studies that evaluated the efficacy and safety of SRS in WHO Grade 2/3 CNS ependymoma patients. Random-effect meta-analysis was employed. RESULTS Fourteen studies with 298 patients and 496 lesions were included. Our meta-analysis demonstrated an overall local tumor control (LTC) rate of 72% (95% CI: 65-79%). LTC rates at 1, 3, and 5 years were 83% (95% CI: 76-88%), 72% (95% CI: 64-78%), and 69% (95% CI: 61-76%), respectively. Progression-free survival (PFS) rates at 1, 3, and 5 years were estimated at 67% (95% CI: 50-80%), 56% (95% CI: 48-64%), and 51% (95% CI: 39-63%), respectively. Additionally, the 5-year overall survival (OS) rate was 58% (95% CI: 48-67%). The incidence of adverse radiation events (ARE) was 20% (95% CI: 12-31%). Meta-regression showed older age correlated with improved tumor control (P = 0.02) and lower ARE (P = 0.06) and radionecrosis rates (P < 0.01), while larger tumor volumes (P = 0.03) and anaplastic histology (P = 0.01) were associated with poorer PFS. CONCLUSIONS SRS is a reasonably valuable therapeutic option in the multimodal management of WHO Grade 2/3 CNS ependymomas, especially for individuals with inoperable, recurrent, or residual lesions. Key patient and tumor characteristics have been analyzed to determine factors potentially impacting treatment outcomes.
Collapse
Affiliation(s)
- Amirhossein Zare
- Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran
| | - Amirhessam Zare
- Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran
| | - Bardia Hajikarimloo
- Department of Neurological Surgery, University of Virginia, Charlottesville, VA, USA
| | - Barbod Mohammadi
- Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran
| | - Jason P Sheehan
- Department of Neurological Surgery, University of Virginia, Charlottesville, VA, USA
| | - Arad Iranmehr
- Neurosurgery Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Gammaknife Center, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
29
|
Ahmed Y, Moawad MHED, Bahtiyarova G, Nabgouri Y, Elkholy M, Wagih RM, Serag I, Alkhawaldeh IM, Abouzid M, Elsayed M. Exploring the Efficacy and Safety of Argatroban as an Adjunct to Antiplatelet Therapy in Ischemic Stroke Patients: A Systematic Review and Meta-analysis. Transl Stroke Res 2025:10.1007/s12975-025-01357-x. [PMID: 40392513 DOI: 10.1007/s12975-025-01357-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2025] [Revised: 04/21/2025] [Accepted: 05/06/2025] [Indexed: 05/22/2025]
Abstract
Acute ischemic stroke (AIS) is a major cause of disability and mortality worldwide. While antiplatelet therapy is standard for secondary prevention, many patients still experience early neurological deterioration (END). Argatroban, a direct thrombin inhibitor, can potentially limit thrombus progression and improve AIS's functional outcomes. This meta-analysis assessed the efficacy and safety of argatroban in combination with single (SAPT) or dual antiplatelet therapy (DAPT) compared to antiplatelets alone. Following PRISMA guidelines, a systematic search of PubMed, Scopus, and Web of Science was conducted until January 2025. Randomized controlled trials (RCTs) and cohort studies evaluating argatroban plus antiplatelets versus antiplatelets alone in AIS patients were included. The primary outcome was a 90-day modified Rankin Score (mRS) of 0-2. Secondary outcomes included mRS 0-1 and mRS 3-5 at 90 days, END, and National Institutes of Health Stroke Scale (NIHSS) improvement, stroke recurrence, intracranial hemorrhage (ICH), symptomatic intracranial hemorrhage (sICH), and mortality. We used the mean difference (MD) for continuous variables and odds ratio (OR) for dichotomous ones at 95% confidence intervals (CI) and a P-value of 0.05. A total of 14 studies (four RCTs and 10 cohort studies) were included. Compared to antiplatelets alone, argatroban significantly improved functional outcomes, increasing the incidence of mRS 0-2 (OR = 1.36 [95%CI: 1.05, 1.76, P = 0.02]) and mRS 0-1 (OR = 1.54 [95%CI: 1.08, 2.2, P = 0.02]) while reducing END (OR = 0.42 [95%CI: 0.21, 0.85, P = 0.02]). Argatroban was also associated with greater NIHSS score improvement (MD = - 0.52 [95%CI: - 0.89, - 0.15, P = 0.005]). No significant differences were observed in mRS 3-5, stroke recurrence, ICH, sICH, or mortality. Subgroup analysis indicated that argatroban combined with DAPT showed the greatest benefits. Argatroban combined with antiplatelet therapy improves functional recovery and reduces END without increasing bleeding risks. These findings support its use, particularly with DAPT, in mild to moderate AIS management. Further large-scale RCTs are needed to optimize dosing strategies and patient selection.
Collapse
Affiliation(s)
- Yousr Ahmed
- Department of Pulmonology and Critical Care, Johns Hopkins University, Baltimore, MD, USA
| | - Mostafa Hossam El Din Moawad
- Alexandria Main University Hospital, Alexandria, Egypt
- Faculty of Medicine, Suez Canal University, Ismailia, Egypt
| | - Gulnaz Bahtiyarova
- Department of Internal Medicine First, Pavlov State Medical University, Saint Petersburg, Russia
| | - Younes Nabgouri
- Department of Internal Medicine First, Pavlov State Medical University, Saint Petersburg, Russia
| | - Mohammed Elkholy
- The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | - Reham M Wagih
- Department of Total Parenteral Nutrition, Alexandria Main University Hospital, Alexandria, Egypt
| | - Ibrahim Serag
- Faculty of Medicine, Mansoura University, Mansoura, Egypt
| | | | - Mohamed Abouzid
- Department of Physical Pharmacy and Pharmacokinetics, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3 St, Poznan, 60-806, Poland.
- Doctoral School, Poznan University of Medical Sciences, Poznan, 60-812, Poland.
| | - Mahmoud Elsayed
- Stroke and Neurovascular Regulation Laboratory, 149 13 Th Street Room 6405, Charlestown, MA, 02129, USA
| |
Collapse
|
30
|
Wei Z, Abdel-Latif ME, Cope J, Oei JL. Eat, sleep and console model of care for managing infants with neonatal abstinence syndrome: a meta-analysis of observational studies. Arch Dis Child 2025:archdischild-2025-328549. [PMID: 40393782 DOI: 10.1136/archdischild-2025-328549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2025] [Accepted: 05/03/2025] [Indexed: 05/22/2025]
Abstract
IMPORTANCE Vigilant clinical assessment is the key to preventing complications, including death, in infants at risk of neonatal withdrawal syndrome. The eat, sleep and console (ESC) is proposed as an alternative to usual care with Finnegan's Neonatal Abstinence Scoring System (FNASS), but whether ESC improves infant outcomes is uncertain. OBJECTIVE To conduct a meta-analysis and systematic review of outcomes of studies comparing ESC to FNASS. DATA SOURCES PubMed, Embase, CINAHL and Cochrane were searched. There was no date restriction. STUDY SELECTION Published data from observational studies published in English were included. Randomised controlled trials, reviews and abstracts were excluded. Data was required to be converted to mean and SD to be included. DATA EXTRACTION AND SYNTHESIS Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were used, and data were independently extracted by multiple observers. Data was pooled using a random-effects model. MAIN OUTCOME AND MEASURES Length of stay (LOS) in days, number of days medicated and proportion of infants medicated were the primary outcomes assessed. It was hypothesised prior to data collection that ESC would be associated with shorter LOS and a lower proportion of infants medicated, given key differences in infant assessment compared with the FNASS. RESULTS 12 studies, all from the USA, were published between 2018 and 2024. 10 quality improvement studies and two cohort studies compared ESC (n=1877) with historical controls using FNASS (n=2199). ESC decreased hospitalisation days (MD -4.11 days, 95% CI -6.04 to -2.19 days; p<0.0001; I2=95%; 10 studies; 3703 participants) and the proportion treated with withdrawal medications (OR 0.36, 95% CI 0.22 to 0.60; I2=89%; RD -0.22; 95% CI -0.34 to -0.10; p<0.0001; I2=93%; 12 studies; 4076 participants). One study assessed physical health up to 1 week after discharge (n=1), three assessed weight loss (n=3) and one assessed cost (n=1). CONCLUSIONS AND RELEVANCE The majority of evidence for a reduction in hospitalisation and need for withdrawal medication with ESC compared with FNASS is derived from quality improvement and cohort studies with almost no health information beyond 1 week after discharge. High-quality trials incorporating physiological measurements of infant stress and longer-term outcomes are needed. REVIEW PROSPECTIVE REGISTRATION CRD42024532169.
Collapse
Affiliation(s)
- Zoe Wei
- Faculty of Children's Health, University of New South Wales, Kensington Campus, Sydney, New South Wales, Australia
- Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia
| | - Mohamed E Abdel-Latif
- Department of Neonatology, Canberra Hospital, Canberra, Australian Capital Territory, Australia
- Department of Public Health, La Trobe University College of Science Health and Engineering, Bundoora, Victoria, Australia
| | - James Cope
- University of New South Wales, Sydney, New South Wales, Australia
| | - Ju-Lee Oei
- School of Paediatrics, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia
- Department of Newborn Care, Royal Hospital for Women, Sydney, New South Wales, Australia
| |
Collapse
|
31
|
Abukmail E, Pradeep NK, Ahmed S, Albarqouni L. Moderate- to Long-Term Effect of Dietary Interventions for Depression and Anxiety : A Systematic Review and Meta-analysis. Ann Intern Med 2025. [PMID: 40388814 DOI: 10.7326/annals-24-03016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/21/2025] Open
Abstract
BACKGROUND Dietary interventions are a potential alternative treatment of depression and anxiety. PURPOSE To evaluate the effects of dietary interventions on depression and anxiety. DATA SOURCES PubMed, Cochrane CENTRAL, EMBASE, CINAHL, and PsycINFO searched from inception until 12 December 2024. Trial registries and forward and backward citation analysis done on 3 January 2025. STUDY SELECTION Randomized controlled trials (RCTs) evaluated the effect of dietary advice with or without food provision compared with no specific dietary advice or active interventions for 3 months or longer on depression and/or anxiety. DATA EXTRACTION Two authors independently screened articles, extracted data, and assessed risk of bias. Primary outcomes included depression and anxiety symptoms at 3 months or longer. Random-effects meta-analyses were done, and the certainty of evidence was assessed. DATA SYNTHESIS Twenty-five RCTs were included. Compared with no specific dietary advice, depressive symptoms might be improved in adults with elevated cardiometabolic risk by dietary advice on calorie restriction (standardized mean difference [SMD], -0.23 [95% CI, -0.38 to -0.09]; low certainty). Low-fat diets may also have very small effects on depressive symptoms in adults with elevated cardiometabolic risk (SMD, -0.03 [CI, -0.04 to -0.01]; low certainty). Evidence on other diets, comparing diets with active comparisons, and on anxiety was limited by study limitations and clinical or methodological heterogeneity. LIMITATION Limited studies did not allow for adequate exploration of heterogeneity. CONCLUSION Calorie restrictions and low-fat diets might reduce depressive symptoms among adults with elevated cardiometabolic risk, but the differences were small and confidence in the findings was low. Evidence on other diets, comparisons to active interventions, and other outcomes is limited. PRIMARY FUNDING SOURCE None. (PROSPERO: CRD42023485953).
Collapse
Affiliation(s)
- Eman Abukmail
- Institute for Evidence Based Healthcare and Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia (E.A., S.A., L.A.)
| | - Neeraj Koloth Pradeep
- Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia (N.K.P.)
| | - Samantha Ahmed
- Institute for Evidence Based Healthcare and Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia (E.A., S.A., L.A.)
| | - Loai Albarqouni
- Institute for Evidence Based Healthcare and Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia (E.A., S.A., L.A.)
| |
Collapse
|
32
|
Badran AS, Khelifa H, Gbreel MI. Exploring the role of melatonin in managing sleep and motor symptoms in Parkinson's disease: a pooled analysis of double-blinded randomized controlled trials. Neurol Sci 2025:10.1007/s10072-025-08221-8. [PMID: 40387966 DOI: 10.1007/s10072-025-08221-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2025] [Accepted: 04/28/2025] [Indexed: 05/20/2025]
Abstract
BACKGROUND Parkinson's disease (PD), a progressive neurodegenerative disorder, often involves sleep disturbances, affecting 88-98% of patients. Melatonin, a sleep-regulating neurohormone, shows the potential to improve sleep quality and non-motor symptoms in PD. AIM To evaluate melatonin's efficacy and safety in PD patients with sleep disorders. METHODS We systematically searched PubMed, Scopus, Web of Science, and Cochrane till January 2025. The risk of bias in the included studies was evaluated using the Cochrane risk-of-bias tool. Dichotomous outcomes were expressed as risk ratios (RRs) with 95% confidence intervals (CIs), while continuous outcomes were reported as mean differences (MDs) with 95% CIs. RESULTS We retrieved 2537 records. Five double-blinded RCTs were finally included. The meta-analysis revealed a significant improvement in sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI), in the melatonin group compared to placebo (MD= -1.88, 95% CI: [-3.07, -0.68], P = 0.002). However, no significant differences were observed for the Epworth Sleepiness Scale (MD= -1.04 CI: [-2.81, 0.73], P = 0.25), total sleep time (MD = 14.85 min CI: [-5.45, 35.16], P = 0.15), sleep efficiency, sleep latency, REM sleep latency, frequency of arousals, or REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ; MD = 0.74, P = 0.50). For Parkinson's disease-related outcomes, melatonin significantly improved Non-Motor Symptom Scale (NMSS) scores but showed no significant effects on UPDRS Part III scores or Parkinson's Disease Quality of Life. CONCLUSION Melatonin improves subjective sleep quality and non-motor symptoms in PD patients with a favorable safety profile, but effects on objective measures and motor symptoms remain inconclusive. TRIAL REGISTRY NUMBER This meta-analysis was registered on PROSPERO. REGISTRATION NUMBER CRD42024619496.
Collapse
Affiliation(s)
- Ahmed Samy Badran
- Faculty of Medicine, Ain Shams University, Cairo Governate, Cairo, 1181, Egypt.
| | - Hamza Khelifa
- Faculty of Medicine, University of Oran 1 Ahmed Ben Bella, Oran, Algeria
| | - Mohamed Ibrahim Gbreel
- Faculty of Medicine, October 6 University, Giza, Egypt
- Department of Cardiology, Egyptian railway Medical Educational Centre, Cairo, Egypt
| |
Collapse
|
33
|
Wozniak P, Krzeszowski T, Kwolek B. Multi-Domain Indoor Dataset for Visual Place Recognition and Anomaly Detection by Mobile Robots. Sci Data 2025; 12:817. [PMID: 40389441 PMCID: PMC12089276 DOI: 10.1038/s41597-025-05124-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2024] [Accepted: 05/01/2025] [Indexed: 05/21/2025] Open
Abstract
Visual location recognition encompasses place recognition (PR) and anomaly detection (AD). These are crucial tasks for autonomous robots to accurately determine the location and the occupied place. To accelerate research in this area, we introduce a multi-domain dataset for indoor visual place recognition and anomaly detection by mobile robots. The dataset includes 89,550 RGB images captured in nine rooms. The data collection process involved both manual recordings and recordings captured by mobile robots. The images depict a wide range of scenarios, including variations in lighting, robot vision, and human activity. Additionally, we provide an analysis of other available datasets referenced in the literature. This article presents a freely available dataset for research on place recognition and presents an example application in the field of anomaly detection. The baseline methods were thoroughly tested and achieved an 80.18% accuracy in anomaly detection for single images and 80.63%-84.18% for image sequences. The article includes a comprehensive presentation of the characteristics of individual image sequences and the most significant conclusions drawn from the research.
Collapse
Affiliation(s)
- Piotr Wozniak
- Faculty of Electrical and Computer Engineering, Rzeszow University of Technology, Rzeszow, 35-959, Poland.
| | - Tomasz Krzeszowski
- Faculty of Electrical and Computer Engineering, Rzeszow University of Technology, Rzeszow, 35-959, Poland
| | - Bogdan Kwolek
- Faculty of Computer Science, AGH University of Krakow, Krakow, 30-059, Poland
| |
Collapse
|
34
|
Amini MR, Majd SS, Salavatizadeh M, Djafari F, Askari G, Hekmatdoost A. The effects of policosanol supplementation on creatinine: a systematic review and dose-response meta-analysis of randomized controlled trials. BMC Complement Med Ther 2025; 25:182. [PMID: 40382621 PMCID: PMC12085850 DOI: 10.1186/s12906-025-04911-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Accepted: 05/01/2025] [Indexed: 05/20/2025] Open
Abstract
OBJECTIVE Policosanol, a compound generated from sugar cane, consists of alcohols such as octacosanol, hexacosanol, and triacontanol, which possess antioxidant properties. Evaluating the impact of this antioxidant on serum creatinine in clinical settings is essential because of the contradictory findings. This comprehensive review and dose-response meta-analysis attempts to evaluate the impact of policosanol supplementation on creatinine levels. METHODS A comprehensive search was performed in bibliographic databases such as Cochrane, PubMed, Google Scholar, Scopus, and Web of Science, covering the period from inception to November 2023. The necessary data was retrieved, and pertinent randomized controlled trials (RCTs) that satisfied the inclusion criteria were included. Weighted mean differences (WMDs) were the reported measure of the pooled effects. To find between-study heterogeneities, the I-squared test was employed. RESULTS A total of 2427 participants were involved in the twenty-one RCTs that were included. A meta-analysis showed that policosanol had no significant change in creatinine levels in participants consuming policosanol compared to placebo consumers (WMD = 0.21 µmol/l; 95% CI = - 0.85 to 1.26; P = 0.70). Policosanol consumption for durations ≥ 24 weeks significantly decreased creatinine, according to subgroup studies. There was a non-linear correlation between changes in creatinine levels and the dosage of prescription policosanol (P non_linearity = 0.002). However, the treatment time did not have a significant impact on creatinine levels in a non-linear manner (P non_linearity = 0.24). CONCLUSION Policosanol supplementation has no significant effect on creatinine levels.
Collapse
Affiliation(s)
- Mohammad Reza Amini
- Student Research Committee, Department of Clinical Nutrition & Dietetics, National Nutrition & Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Sara Sadeghi Majd
- Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran
| | - Marieh Salavatizadeh
- Department of Clinical Nutrition & Dietetics, National Nutrition & Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Farhang Djafari
- School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, Australia
| | - Gholamreza Askari
- Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Azita Hekmatdoost
- Department of Clinical Nutrition & Dietetics, National Nutrition & Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Clinical Nutrition, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
35
|
Takyi A, Soma A, Przybylska M, Harriss E, Barnes KI, Dahal P, Guérin PJ, Stepniewska K, Carrara VI. Efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria in Africa: a WWARN systematic review. Malar J 2025; 24:153. [PMID: 40380136 DOI: 10.1186/s12936-025-05393-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2024] [Accepted: 04/29/2025] [Indexed: 05/19/2025] Open
Abstract
BACKGROUND Africa bears the highest double burden of HIV and malaria worldwide. In 2023, an estimated 25.9 million people were living with HIV (PLHIV), and 246 million malaria cases were diagnosed in Africa. Malaria patients co-infected with HIV are considered at a higher risk of failing malaria treatment, according to the World Health Organization (WHO) guidelines. This systematic literature review aims to assess the treatment outcomes following artemisinin-based combination therapy (ACT) in PLHIV. METHODS The literature search was conducted up to April 2022 in the following databases: MEDLINE, EMBASE, Web of Science, Cochrane Central, WHO Global Index Medicus, Clinicaltrials.gov, and the WorldWide Antimalarial Resistance Network (WWARN) Clinical Trial Library. Studies describing any malaria treatment outcomes or anti-malarial drug exposure in PLHIV treated for uncomplicated Plasmodium falciparum malaria infection were eligible for inclusion. RESULTS A total of 26 articles describing 19 studies conducted between 2003 and 2017 in six countries were included in this review; it represented 2850 malaria episodes in PLHIV across various transmission settings. The most studied artemisinin-based combination was artemether-lumefantrine (in 16 studies). PLHIV were treated with various antiretroviral therapy (ART) regimens, namely efavirenz (EFV), nevirapine (NVP), atazanavir-ritonavir (ATVr), lopinavir-ritonavir (LPV/r), and/or on prophylaxis with trimethoprim-sulfamethoxazole (TS), or were untreated (in 3 studies). There was no evidence of an increased risk of recrudescence in PLHIV compared to those without HIV. When treated with artemether-lumefantrine, PLHIV receiving LPV/r had a lower risk of malaria recurrence compared to PLHIV on NVP-based or EFV-based ART, or those without HIV. LPV/r increased lumefantrine exposure and EFV-treated patients had a reduced exposure to both artemether and lumefantrine; NVP reduced artemether exposure only. CONCLUSIONS Limited data on ACT outcomes or drug exposure in PLHIV in Africa remains a reality to date, and the effect of antivirals appears inconsistent in the literature. Considering the heterogeneity in study designs, these review's findings support conducting an individual patient data meta-analysis to explore the impact of antiretroviral therapy on anti-malarial treatment. TRIAL REGISTRATION The protocol for the original search was published on PROSPERO with registration number CRD42018089860.
Collapse
Affiliation(s)
- Abena Takyi
- Department of Child Health, Korle Bu Teaching Hospital, Accra, Ghana
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO), Oxford, UK
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
| | - Aboubakar Soma
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO), Oxford, UK
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
- Centre MURAZ/Institut National de Santé Publique (INSP), Bobo-Dioulasso, Burkina Faso
- Département Médecine-Pharmacopée Traditionnelle/Pharmacie (MEPHATRA/Ph), Institut de Recherche en Sciences de la Santé (IRSS), Ouagadougou, Burkina Faso
| | | | - Eli Harriss
- Bodleian Health Care Libraries, University of Oxford, Oxford, UK
| | - Karen I Barnes
- Infectious Diseases Data Observatory (IDDO), Oxford, UK
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
- Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
| | - Prabin Dahal
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO), Oxford, UK
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
| | - Philippe J Guérin
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO), Oxford, UK
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
| | - Kasia Stepniewska
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- Infectious Diseases Data Observatory (IDDO), Oxford, UK
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
| | - Verena I Carrara
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Infectious Diseases Data Observatory (IDDO), Oxford, UK.
- WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK.
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
| |
Collapse
|
36
|
Kofod L, Pedersen M, Andersen M, Christensen E, Pedersen P, Alipour H, Egerup P, Christiansen OB, Kesmodel US. Intravenous immunoglobulin versus placebo in recurrent pregnancy loss: A systematic review and meta-analysis of randomized trials. J Reprod Immunol 2025; 170:104541. [PMID: 40403511 DOI: 10.1016/j.jri.2025.104541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2025] [Revised: 03/28/2025] [Accepted: 05/15/2025] [Indexed: 05/24/2025]
Abstract
Recurrent pregnancy loss (RPL) affects 1-2 % of fertile couples, with immunological factors increasingly implicated in unexplained cases. Currently, no convincing treatment exists. Intravenous immunoglobulin (IVIg) has been explored as a potential treatment, but results have been inconsistent. This study evaluates whether IVIg affects live birth rates in women with RPL in subsequent pregnancies. We searched PubMed, Embase, and Cochrane libraries for relevant randomized controlled trials up to March 20, 2023, and contacted authors for individual patient data. Trials involving women with two or more consecutive pregnancy losses who received IVIg or placebo before or during the first trimester were included. Primary outcomes were live birth and clinical pregnancy rates, with secondary outcomes including pregnancy loss rate, side effects, adverse events, and perinatal outcomes. Risk of bias and certainty of evidence (GRADE) were evaluated. Ten studies involving 662 women were included. The intention-to-treat analysis showed no significant difference in live birth rates between IVIg and placebo groups (RR: 1.02, 95 % CI: 0.86-1.22, p = 0.78, GRADE: moderate). However, per-protocol analysis indicated an increased live birth rate with IVIg (RR: 1.23, 95 % CI: 1.00-1.50, GRADE: low). Live birth rates after IVIg improved with the number of previous losses, especially in patients with ≥ 6 losses (RR: 5.26 (1.58-17.53)). While IVIg therapy did not show a significant improvement in live birth rates overall, future research should focus on identifying specific patient subgroups, such as those with multiple prior losses, who may benefit most from this treatment.
Collapse
Affiliation(s)
- Louise Kofod
- Center for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark.
| | - Madicken Pedersen
- Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark
| | - Mette Andersen
- Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark
| | - Emilie Christensen
- Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark
| | - Pernille Pedersen
- Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark
| | - Hiva Alipour
- Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Selma Lagerløfs Vej 249, Gistrup 9260, Denmark
| | - Pia Egerup
- Copenhagen University Hospital Hvidovre, Department of Obstetrics and Gynecology, Kettegård Alle 36, Hvidovre 2650, Denmark
| | - Ole Bjarne Christiansen
- Center for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark
| | - Ulrik Schiøler Kesmodel
- Department of Obstetrics and Gynaecology, Aalborg University Hospital, Reberbansgade 15, Aalborg 9000, Denmark and Department of Clinical Medicine, Aalborg University, Selma Lagerløfs 249, Gistrup 9260, Denmark
| |
Collapse
|
37
|
Edwards L, Parker GJM, Waterton JC, Tibiletti M. Longitudinal relaxation rate ( R 1 ) in lung: a systematic review and meta-analysis. MAGMA (NEW YORK, N.Y.) 2025:10.1007/s10334-025-01259-x. [PMID: 40377842 DOI: 10.1007/s10334-025-01259-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Revised: 04/11/2025] [Accepted: 04/23/2025] [Indexed: 05/18/2025]
Abstract
OBJECTIVE The lung magnetic resonance longitudinal relaxation rate R 1 varies with disease but reported values in healthy subjects (HS) also differ markedly between studies. OBJECTIVE To evaluate the reported values and variances of observed R 1 accounting for field strength B 0 , acquisition method, and disease. MATERIALS AND METHODS A systematic literature search was performed to identify studies quantifying R 1 or its reciprocal T 1 . The relationship between field strength and observed R1 was analysed in all healthy subject data. Data were fit to the heuristic equationR 1 = B ∗ ( B 0 A ) . The variances between-study bs , within-study-between-subject wsbs , and within-study-within-subject wsws , in HS were assessed. Linear correlation between observed R1 and TE was also investigated. RESULTS Fifty-nine papers were selected, 50 quantifying R1 in HS and 20 in disease, representing 1559 human and non-human subjects, with B 0 ranging from 0.2 T to 9.4 T. In HS, the result of the fit on all healthy subjects was A = -0.227 ± 0.020 s-1 T-1, B = 0.923 ± 0.014 s-1 with variance components b s > w s b s > w s w s . The reference values for R1 at B 0 between 0.55 T and 7 T were derived. For inversion recovery with gradient echo readout at 1.5 T, a previously observed negative relationship between R 1 and TE was confirmed. DISCUSSION We provide reference values for lung R 1 across all commonly used field strengths. The variation in HS lung observed R 1 reported in different studies in different centres likely reflects methodological differences. Investigators wishing to compare lung R 1 values with previous reports should take account of this irreproducibility, and multicentre projects should standardise to minimise between-centre variance.
Collapse
Affiliation(s)
- Lucy Edwards
- Bioxydyn Limited, St James Tower, 7 Charlotte Street, Manchester, M1 4DZ, UK
| | - Geoff J M Parker
- Bioxydyn Limited, St James Tower, 7 Charlotte Street, Manchester, M1 4DZ, UK.
- Department of Medical Physics and Biomedical Engineering, UCL Hawkes Institute, University College London, 1St Floor 90 High Holborn, London, WC1 V 6LJ, UK.
| | - John C Waterton
- Bioxydyn Limited, St James Tower, 7 Charlotte Street, Manchester, M1 4DZ, UK
- Centre for Imaging Sciences, University of Manchester, Manchester, UK
| | - Marta Tibiletti
- Bioxydyn Limited, St James Tower, 7 Charlotte Street, Manchester, M1 4DZ, UK
| |
Collapse
|
38
|
Chen Y, Luo Z, Cheng L, Wang Q, Zou F, Warsi MA, Lin Y. Development and Validation of the China Dietary Inflammatory Index (CHINA-DII). Nutrients 2025; 17:1687. [PMID: 40431426 PMCID: PMC12114556 DOI: 10.3390/nu17101687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2025] [Revised: 05/09/2025] [Accepted: 05/14/2025] [Indexed: 05/29/2025] Open
Abstract
Objective: To develop and validate the China Dietary Inflammatory Index (CHINA-DII) for Chinese adults. Methods: A systematic literature search was conducted to identify studies published between 2009 and 2024 reporting dietary intake levels among Chinese adults. After applying inclusion and exclusion criteria and evaluating study quality, a dietary intake database for Chinese adults was established. Following the methodology of the original Dietary Inflammatory Index (DII), the CHINA-DII was constructed and validated. A total of 256 newly diagnosed gastric cancer patients who visited the Union Hospital of Fujian Medical University between June 2023 and November 2024 were recruited. Demographic information, clinical data, and dietary data based on a food frequency questionnaire (FFQ) were collected. Spearman rank correlation was used to assess the relationship between CHINA-DII scores and high-sensitivity C-reactive protein (hs-CRP) levels. Results: A total of 33 eligible studies were included to develop a dietary intake database encompassing 27 dietary components. Among the 256 gastric cancer patients, the average CHINA-DII score was -1.91 ± 0.35, and the mean hs-CRP level was 3.68 ± 2.35 mg/L. CHINA-DII scores were positively correlated with hs-CRP levels (r = 0.20, p ≤ 0.001). Multivariate logistic regression analysis showed that individuals with higher CHINA-DII scores had a 1.90-fold increased risk of hs-CRP ≥ 3 mg/L compared to those with lower scores (odds ratio, OR = 1.90; 95% confidence interval, 95%CI: 1.01-3.55). For each 1-standard-deviation (SD) increase in CHINA-DII score, the risk of hs-CRP ≥ 3 mg/L increased by 1.50 times (OR = 1.50, 95% CI: 1.10-2.06). Conclusions: The CHINA-DII developed in this study effectively reflects the potential inflammatory impact of dietary intake in Chinese adults and is significantly positively associated with the inflammatory marker hs-CRP, indicating good validity and applicability.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Yulan Lin
- Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; (Y.C.); (Z.L.); (L.C.); (Q.W.); (F.Z.); (M.A.W.)
| |
Collapse
|
39
|
Guo Y, Sun S, Wang Y, Chen S, Kou Z, Yuan P, Han W, Yu X. Microbial dysbiosis in obstructive sleep apnea: a systematic review and meta-analysis. Front Microbiol 2025; 16:1572637. [PMID: 40444003 PMCID: PMC12119640 DOI: 10.3389/fmicb.2025.1572637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2025] [Accepted: 05/01/2025] [Indexed: 06/02/2025] Open
Abstract
Background The association between the microbiota and obstructive sleep apnea (OSA) remains understudied. In this study, we conducted a comprehensive systematic review and meta-analysis of studies investigating the diversity and relative abundance of microbiota in the gut, respiratory tracts and oral cavity of patients with OSA, aiming to provide an in-depth characterization of the microbial communities associated with OSA. Methods A comprehensive literature search across PubMed, the Cochrane Library, Web of Science, and Embase databases were conducted to include studies published prior to Dec 2024 that compared the gut, respiratory and oral microbiota between individuals with and without OSA. The findings regarding alpha-diversity, beta-diversity, and relative abundance of microbiota extracted from the included studies were summarized. This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the study protocol was registered with PROSPERO (CRD42024525114). Results We identified a total of 753 articles, out of which 27 studies were ultimately included in the systematic review, involving 1,381 patients with OSA and 692 non-OSA populations, including 1,215 OSA patients and 537 non-OSA populations in adults and 166 OSA patients and 155 non-OSA populations in children. The results of alpha diversity revealed a reduction in the Chao1 index (SMD = -0.40, 95% CI = -0.76 to -0.05), Observed species (SMD = -0.50, 95% CI = -0.89 to -0.12) and Shannon index (SMD = -0.27, 95% CI = -0.47 to -0.08) of the gut microbiota in patients with OSA. Beta diversity analysis indicated significant differences in the gut, respiratory and oral microbial community structure between individuals with OSA and those without in more than half of the included studies. Furthermore, in comparison to the non-OSA individuals, the gut environment of patients with OSA exhibited an increased relative abundance of phylum Firmicutes, along with elevated levels of genera Lachnospira; conversely, there was a decreased relative abundance of phylum Bacteroidetes and genus Ruminococcus and Faecalibacterium. Similarly, within the oral environment of OSA patients, there was an elevated relative abundance of phylum Actinobacteria and genera Neisseria, Rothia, and Actinomyces. Conclusion Patients with OSA exhibit reduced diversity, changes in bacterial abundance, and altered structure in the microbiota, especially in the gut microbiota. The results of this study provide basic evidence for further exploration of microbiome diagnostic markers and potential intervention strategies for OSA.
Collapse
Affiliation(s)
- Yang Guo
- School of Medical Laboratory, Shandong Second Medical University, Weifang, China
| | - Shuqi Sun
- School of Clinical Medicine, Shandong Second Medical University, Weifang, China
| | - Yaoyao Wang
- Department of Medicine, Qingdao University, Qingdao, China
| | - Shiyang Chen
- School of Clinical Medicine, Shandong Second Medical University, Weifang, China
| | - Ziwei Kou
- Department of Medicine, Qingdao University, Qingdao, China
| | - Peng Yuan
- Qingdao Key Laboratory of Common Diseases, Department of Respiratory and Critical Medicine, Department of Emergency, Department of General Practice, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China
| | - Wei Han
- Qingdao Key Laboratory of Common Diseases, Department of Respiratory and Critical Medicine, Department of Emergency, Department of General Practice, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China
| | - Xinjuan Yu
- Clinical Research Center, Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China
| |
Collapse
|
40
|
Ayarde-Henríquez L, Lupi J, Ballotta B, Dooley S. Evans-Polanyi-like Formulations for Rapidly Predicting Key Depolymerization Barriers in Xylopyranoses: Toward the Faster Development of Kinetic Models for Hemicellulose Pyrolysis. J Phys Chem A 2025. [PMID: 40367517 DOI: 10.1021/acs.jpca.5c00675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2025]
Abstract
This work elucidates Evans-Polanyi-like (EPL) relations to rapidly estimate the standard activation enthalpy of three ubiquitous reaction classes playing a central role in hemicellulose pyrolysis: ring-opening, ring contraction, and elimination. These models bypass computing the reaction enthalpy by leveraging computationally cheap local and global electron-density-based chemical reactivity descriptors, such as Fukui's functions (f), electron population of C-O bonds (N), and the gross intrinsic strength bond index (Δgpair), evaluated for reactants solely. More than 270 reactions observed in twenty-eight functionalized β-d-xylopyranoses, the hemicellulose building block, are used under the 20-80% partition scheme for validating-deriving purposes. By using multilinear regression analysis, four EPL equations are proposed for informing barriers at the M06-2X/6-311++G(d,p), CBS-QB3, G4, and DLPNO-CCSD(T)-F12/cc-pVTZ-F12//M06-2X/6-311++G(d,p) levels. An adjusted coefficient of determination of 0.80 characterizes these parametric polynomials. Moreover, MAE and RMSE of ≈3.3 and ≈4.1 kcal mol-1 describe the performance of the best-fitting models at DFT and G4. Conversely, the highest values, MAE = 3.6 and RMSE = 4.7 kcal mol-1, are associated with the CBS-QB3 level. The benchmarking of the computed activation enthalpies at 298 K yields simple functions for high-level estimations from low levels of theory with R2 ranging from 0.94 to 0.98. Extrapolating the DPLNO barriers to the complete basis set limit tends to lower them by 0.63 kcal mol-1. EPL expressions are tailored to facilitate the development of chemical kinetic models for hemicellulose pyrolysis, as the reactant structure is the only input required.
Collapse
Affiliation(s)
- Leandro Ayarde-Henríquez
- School of Physics, Trinity College Dublin, Dublin 2 D02 PN40, Ireland
- AMBER, Advanced Materials and BioEngineering Research Centre, Dublin 2 D02 PN40, Ireland
| | - Jacopo Lupi
- CNR-ICCOM, Consiglio Nazionale delle Ricerche, Via Giuseppe Moruzzi 1, Pisa I-56124, Italy
| | - Bernardo Ballotta
- School of Physics, Trinity College Dublin, Dublin 2 D02 PN40, Ireland
- AMBER, Advanced Materials and BioEngineering Research Centre, Dublin 2 D02 PN40, Ireland
| | - Stephen Dooley
- School of Physics, Trinity College Dublin, Dublin 2 D02 PN40, Ireland
- AMBER, Advanced Materials and BioEngineering Research Centre, Dublin 2 D02 PN40, Ireland
| |
Collapse
|
41
|
Bosmans J, Moyaert J, van Eetvelde J, Gillebert CR. Navigational difficulties after stroke: A systematic review and meta-analysis. Clin Neuropsychol 2025:1-29. [PMID: 40366853 DOI: 10.1080/13854046.2025.2498044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2024] [Accepted: 04/21/2025] [Indexed: 05/16/2025]
Abstract
OBJECTIVE Navigation, the ability to find one's way from one place to another, is an important cognitive skill for maintaining autonomy in daily life. Several findings indicate that navigational ability can be impaired after stroke. However, navigation is rarely assessed in clinical practice, and evidence-based recommendations for suitable diagnostic tools are lacking. Furthermore, the scientific literature does not provide a meta-analytic estimation of the prevalence of post-stroke navigational impairments. This systematic review aims to provide an overview of the tools to assess navigational difficulties after stroke, including their psychometric properties, and determine the prevalence of post-stroke navigational difficulties. METHOD Three investigators independently and systematically searched publications performing assessments of navigation in the stroke population, with a fourth independent investigator consulted when discrepancies were present. References of the retrieved articles were hand searched for relevant articles. RESULTS The systematic review included 19 studies, reporting on 19 different approaches to assess objective and/or subjective navigation skills, each with different psychometric properties. The pooled effect size, using a random-effects model including data from a subset of 8 out of the 19 included studies, demonstrated a prevalence of post-stroke navigation impairments of 35% (95% CI: 0.29-0.42). However, this model was significantly heterogeneous. CONCLUSIONS Navigational difficulties are a common neuropsychological deficit after stroke. However, navigation is a broad construct and a subdivision to reduce heterogeneity in navigation ability is recommended, e.g. by categorizing navigation into landmark-, location-, and path-based navigation impairment. The inclusion of objective and subjective assessments of navigation is recommended in clinical practice. REGISTRATION The protocol was registered at the PROSPERO international prospective register of systematic reviews (PROSPERO ID: CRD42023491346).
Collapse
Affiliation(s)
- Joyce Bosmans
- Department of Brain and Cognition, Leuven Brain Institute, KU Leuven, Leuven, Belgium
| | - Julie Moyaert
- Department of Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium
- University Department of Otorhinolaryngology-Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium
| | - Julie van Eetvelde
- REVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium
- Research Group MOVANT, Department of Rehabilitation Sciences and Physiotherapy (REVAKI), University of Antwerp, Wilrijk, Belgium
- Pain in Motion International Research Consortium (PiM), Brussels, Belgium
| | - Céline R Gillebert
- Department of Brain and Cognition, Leuven Brain Institute, KU Leuven, Leuven, Belgium
- Centre for Translational Psychological Research (TRACE), KU Leuven - Hospital East-Limbourgh, Genk, Belgium
| |
Collapse
|
42
|
Fallahi MS, Maroufi SF, Parmis Maroufi S, Khorasanizadeh M, de Macêdo Filho LJM, Margetis K, Guha D, Tatsui CE, Mansouri A. Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis. J Neurooncol 2025:10.1007/s11060-025-05064-3. [PMID: 40358802 DOI: 10.1007/s11060-025-05064-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2025] [Accepted: 04/25/2025] [Indexed: 05/15/2025]
Abstract
BACKGROUND Minimally invasive techniques such as vertebroplasty, kyphoplasty, radiofrequency ablation, and stereotactic body radiotherapy have been widely used to manage spinal metastases. Among these, percutaneous cryoablation (PCA) has emerged as a promising option for local tumor control and pain management, offering targeted treatment with minimal damage to surrounding tissues. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of PCA for spinal metastases. METHODS A systematic review was conducted using PubMed and Embase databases to identify studies that reported outcomes of PCA for spinal metastases. The reported radiologic, clinical, and complication outcomes were then combined and analyzed using meta-analytic methods including the calculation of pooled means and proportions, subgroup analysis, and meta-regression. RESULTS Eleven studies, including 229 patients, met inclusion criteria and were analyzed. Patients had a mean age of 61.8 years, with 60.6% being female. Breast (18.6%), lung (16.0%), and thyroid (8.0%) were the most common primary cancer sites. PCA was primarily conducted under general anesthesia (47.5%) and with CT/MRI guidance (93.9%). Local tumor control was achieved in 70.5% of cases over a mean follow-up of 12.6 months. Pain severity significantly decreased postoperatively, with a mean reduction of 4.5 points (P < 0.0001). Major and minor complication rates were 2.0% and 4.8%, respectively. CONCLUSIONS PCA is an effective alternative treatment for spinal metastases, offering pain relief and local tumor control with low complication rates in appropriately selected patients. However, tumor location and patient age may influence treatment outcomes, underscoring the need for individualized treatment planning.
Collapse
Affiliation(s)
- Mohammad Sadegh Fallahi
- Neurosurgical Research Network (NRN), Universal Scientific Education and Research Network (USERN), Tehran, Iran
- Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran
| | - S Farzad Maroufi
- Neurosurgical Research Network (NRN), Universal Scientific Education and Research Network (USERN), Tehran, Iran
- Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, USA
| | - S Parmis Maroufi
- Neurosurgical Research Network (NRN), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | | | | | | | - Daipayan Guha
- Division of Neurosurgery, Hamilton General Hospital, McMaster University, Hamilton, ON, Canada
| | - Claudio E Tatsui
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Alireza Mansouri
- Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
| |
Collapse
|
43
|
Brinsley J, Schmidt M, Curtis R, Simpson CE, Edwards J, Eglitis EE, Gosse G, Broad M, Jardine B, Taddeo E, Banati P, Maher C. Effectiveness of peer-led health behaviour interventions on adolescent's mental health and wellbeing: a systematic review and meta-analysis. Sci Rep 2025; 15:16480. [PMID: 40355577 PMCID: PMC12069703 DOI: 10.1038/s41598-025-01053-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Accepted: 05/02/2025] [Indexed: 05/14/2025] Open
Abstract
Mental health disorders affect 15% of youth aged 10-19 years globally, typically emerging before age 15. While school-based peer-led programs show promise in improving physical health behaviours by leveraging existing social networks, reducing stigma, and demonstrating high implementation feasibility, their effectiveness for mental health outcomes remains unclear. This systematic review examined controlled trials of school-based, peer-led lifestyle interventions (physical activity, diet, or sleep) reporting mental health outcomes in adolescents aged 10-19 years. Six electronic databases were searched up to March 28, 2024. Seven studies met inclusion criteria, encompassing 7,060 adolescents from 151 schools across the UK, USA, Canada, and Norway. Interventions varied in frequency and duration, with six focusing on physical activity and one on diet. Meta-analyses revealed no significant effects for psychological difficulties (MD = 0.60, 95% CI -3.52 to 4.72; p = 0.32, k = 2), self-efficacy for physical activity (SMD = 0.18, 95% CI -3.08 to 3.44; p = 0.61, k = 2), or wellbeing (SMD = 0.0, 95% CI -2.94 to 2.94; p = 1.0, k = 2). These findings, while requiring cautious interpretation, highlight the pressing need for more comprehensive and rigorous research to better understand the impact of peer-led interventions on mental health outcomes.
Collapse
Affiliation(s)
- Jacinta Brinsley
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia.
| | - Matthew Schmidt
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Rachel Curtis
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Catherine Em Simpson
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Jessica Edwards
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Emily E Eglitis
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Georgia Gosse
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Michael Broad
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Bryony Jardine
- Centre for Social Impact, Flinders University, Adelaide, Australia
| | - Elizabeth Taddeo
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| | - Prerna Banati
- Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland
| | - Carol Maher
- Alliance for Research in Exercise, Nutrition and Activity, Allied Health and Human Performance, University of South Australia, 108 North Terrace, Adelaide, 5000, Australia
| |
Collapse
|
44
|
Gholami A, Amirkalali B, Hariri M. Can soy isoflavones in combination with soy protein change serum levels of C-reactive protein among patients with chronic inflammatory diseases? A systematic review and meta-analysis on randomized controlled trials. JOURNAL OF HEALTH, POPULATION, AND NUTRITION 2025; 44:154. [PMID: 40355968 PMCID: PMC12070792 DOI: 10.1186/s41043-025-00902-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/08/2024] [Accepted: 04/24/2025] [Indexed: 05/15/2025]
Abstract
BACKGROUND C-reactive protein (CRP) is one of the most important markers for assessing inflammation status and its increased concentration in blood is associated with many chronic diseases in humans. The aim of this study was to reveal the effect of soy isoflavones containing soy protein on serum levels of CRP in adult population with chronic inflammatory diseases. MATERIALS AND METHODS We searched databases including PubMed, Cochrane Library, ISI Web of Science, Scopus, and clinicalTrials.gov up to March 2025. We used random effects model to calculate the heterogeneity and the overall effects. RESULTS Twenty-seven articles were involved in the systematic review and twenty-two articles with thirty-four effect sizes were considered for meta-analysis. The overall estimates revealed that soy isoflavones containing soy protein significantly decreased serum levels of CRP in comparison with control group (weighted mean difference (WMD)= -0.49 mg/L; 95% confidence interval (CI): -0.74, -0.25; P = 0 < 0.001). CONCLUSION Although our results clearly showed soy isoflavones containing soy protein can have decreasing effect on inflammation in participants with chronic inflammatory disease, more large-scale and high quality interventional studies still need to be done to clarify our results.
Collapse
Affiliation(s)
- Ali Gholami
- Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran
- Workplace Health Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran
| | - Bahareh Amirkalali
- Gastrointestinal & Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Mitra Hariri
- Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
- Healthy Ageing Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran.
| |
Collapse
|
45
|
Bahari H, Shahraki Jazinaki M, Aliakbarian M, Rashidmayvan M, Golafrouz H, Rahnama I, Khodashahi R, Malekahmadi M. Propolis supplementation on inflammatory and oxidative stress biomarkers in adults: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 2025; 12:1542184. [PMID: 40421039 PMCID: PMC12104767 DOI: 10.3389/fnut.2025.1542184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2024] [Accepted: 04/25/2025] [Indexed: 05/28/2025] Open
Abstract
Background Although a large number of trials have observed the anti-inflammatory properties of propolis, the currently available research remains controversial regarding its beneficial health effects. Hence, the purpose of this study was to examine the effect of propolis on inflammatory and oxidative stress markers in adults. Methods A comprehensive search was performed in Scopus, Web of Science, and PubMed/Medline to find relevant randomized controlled trials (RCTs) until January 2024. The overall effect sizes were calculated using the random-effects model and expressed as weighted mean differences (WMD) with a 95% confidence interval (CI). The possible heterogeneity between included trials was assessed by performing Cochran's Q test. Results In total, 27 trials with 29 treatment arms were eligible for inclusion in this review. This meta-analysis revealed that propolis consumption led to a significant decrease in C-reactive protein (CRP) (WMD: -1.23; 95%CI: -1.76, -0.69; p < 0.001), Interleukin-6 (IL-6) (WMD: -1.52; 95%CI: -2.10, -0.93; p < 0.001), Tumor necrosis factor-α (WMD: -1.15; 95%CI: -1.75, -0.55; p < 0.001), and Monocyte chemoattractant protein-1 (MCP-1) (WMD: -35.33; 95%CI: -50.28, -20.37; p < 0.001), and a significant increase in total antioxidant capacity (TAC) (WMD: 0.32; 95%CI: 0.12, 0.51; p = 0.001), Glutathione (GSH) (WMD: 4.71; 95%CI: 3.17, 6.25; p < 0.001), and Glutathione peroxidase (GPx) (WMD: 44.75; 95%CI: 5.10, 84.40; p = 0.02). However, there were no significant effects on IL-10, IL-2, IL-8, pro-oxidant-antioxidant balance (PAB), malondialdehyde (MDA), and superoxide dismutase (SOD) in comparison to the control group. Conclusion Propolis supplementation appears effective in reducing inflammation and oxidative stress by enhancing antioxidant capacity and reducing specific inflammatory markers. However, variations in study designs, dosages, and participant characteristics contribute to the heterogeneity of results. Further well-designed RCTs are needed to confirm these findings and determine the optimal dosage and long-term effects. Given its potential anti-inflammatory and antioxidant properties, propolis may serve as a complementary approach in managing inflammation-related conditions, though its clinical application requires further validation. Systematic review registration https://clinicaltrials.gov/, identifier CRD42023474033.
Collapse
Affiliation(s)
- Hossein Bahari
- Transplant Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Mohsen Aliakbarian
- Transplant Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad Rashidmayvan
- Department of Nutrition, Food Sciences and Clinical Biochemistry, School of Medicine, Social Determinants of Health Research Center, Gonabad University of Medical Science, Gonabad, Iran
| | - Haniyeh Golafrouz
- Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Iman Rahnama
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Rozita Khodashahi
- Transplant Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
- Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mahsa Malekahmadi
- Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
46
|
Boulianne M, Verret M, O'Connor S, Savard X, Neveu X, Marcoux C, Costerousse O, Gagnon MA, Zhang H, Beaulé L, Lamothe-Boucher F, Turgeon AF. Intraperitoneal local anesthetics for postoperative pain management following intra-abdominal surgery: a systematic review and meta-analysis. BMC Anesthesiol 2025; 25:235. [PMID: 40348992 PMCID: PMC12065176 DOI: 10.1186/s12871-025-03105-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2024] [Accepted: 04/28/2025] [Indexed: 05/14/2025] Open
Abstract
IMPORTANCE Although intraperitoneal local anesthetics are commonly used following intra-abdominal surgical procedures, the level of evidence supporting their use for postoperative pain management remains uncertain. OBJECTIVE To evaluate the effect of intraperitoneal local anesthetics on postoperative pain following intra-abdominal surgery. DATA SOURCES Medline (PubMed), Embase (Embase.com), CENTRAL, Web of science and ClinicalTrials.gov databases were searched from their inception to July 15th, 2022. TRIAL SELECTION Randomized controlled trials comparing IPLA to placebo, usual care or other analgesic regimens among patients of any age undergoing any type of surgery. DATA EXTRACTION AND SYNTHESIS Trial selection, data extraction, risk of bias assessment and the certainty of evidence were conducted in duplicate independently. Meta-analyses were performed using random effect models. MAIN OUTCOMES AND MEASURES The co-primary outcomes were abdominal pain intensity at 6, 12, 24, 48, and 72 h after surgery. Secondary outcomes included postoperative nausea and vomiting, opioid use, recovery of gastrointestinal transit, length of hospital stay, postoperative chronic pain, persistent postoperative opioid use, quality of recovery and adverse events. RESULTS A total of 150 trials (n = 11,821 participants were included in our systematic review (97% of trials among adults). Intraperitoneal local anesthetics reduced postoperative pain intensity at 6 h (-0.86 point [95%CI -1.02 to -0.70]), 12 h (-0.74 point [95%CI -0.93 to -0.55]), 24 h (-0.65 point [95%CI -0.82 to -0.48]), and 48 h (-0.51 point [95%CI -0.70 to -0.31]), but not at 72 h (-0.38 point [95%CI -1.04 to 0.27]), with very low to low certainty of evidence. Modelled risk difference for achieving the clinically important effect and subgroup analyses among participants with moderate or high pain showed potential clinically significant effect from IPLA. Opioid use at 24 h (-10.4 mg of oral morphine equivalent [95% CI -13.1 to -7.6]), postoperative nausea and vomiting (RR 0.79 [95% CI -0.71 to 0.88]), and time to gastrointestinal transit recovery (-3.80 h [95% CI -7.54 to -0.07]) were also reduced. We found no association for other outcomes. CONCLUSION AND RELEVANCE Intraperitoneal local anesthetics may be associated with a small analgesic effect following intra-abdominal surgery. Considering the low to very low level of evidence supporting these findings, along with the limited data on adverse effects and long-term outcomes, their adoption as a standard of care intervention cannot be recommended at this stage. REGISTRATION NUMBER CRD42018115062.
Collapse
Affiliation(s)
- Mélissa Boulianne
- Department of Surgery, CISSS du Bas Laurent, Rimouski, Québec, Canada
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Michael Verret
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada.
- Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Université Laval, Québec City, Québec, Canada.
| | - Sarah O'Connor
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Xavier Savard
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Xavier Neveu
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Camille Marcoux
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
- CISSS de Chaudière-Appalaches, Montmagny, Québec, Canada
| | - Olivier Costerousse
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Marc-Aurèle Gagnon
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Huixin Zhang
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Laurence Beaulé
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Frédérique Lamothe-Boucher
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
| | - Alexis F Turgeon
- CHU de Québec- Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit (Trauma- Emergency- Critical Care Medicine), Québec city, Canada
- Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Université Laval, Québec City, Québec, Canada
| |
Collapse
|
47
|
Li W, Liang X, Sun N, Zhang D. Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials. BMC Endocr Disord 2025; 25:124. [PMID: 40336001 PMCID: PMC12056997 DOI: 10.1186/s12902-025-01948-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2024] [Accepted: 04/28/2025] [Indexed: 05/09/2025] Open
Abstract
AIMS To verify the influence of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on renal function parameters in type 2 diabetes based on well-known randomized controlled trials (RCTs). METHODS PubMed, Cochrane, Web of Science, Embase, and grey literature were searched for RCTs published until December 24, 2024. The quality of the RCTs was assessed using the Cochrane risk-of-bias tool. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were calculated for continuous variables using meta-analysis. The primary outcomes were composite renal function parameters, including serum creatinine (Cr) levels, estimated glomerular filtration rate (eGFR), urinary albumin excretion (UAE), and urinary albumin-to-creatinine ratio (UACR). RESULTS Pooled data from 24 studies revealed that GLP-1 RA positively influenced renal outcomes in the type 2 diabetes group to some extent compared with that in the control group. GLP- 1 RA decreased serum creatinine levels (WMD=-0.10, 95%CI -0.19 to -0.01, I2 = 33%, P < 0.05), eGFR(WMD = 0.54, 95% CI 0.19 to 0.90, I2 = 27%, P < 0.05), UAE (WMD=-11.92, 95% CI - 23.50 to - 0.33, I2 = 0%, P < 0.05) and UACR (WMD: -1.01 mg/g, 95% CI:-1.68, -0.34, I2 = 15%, P < 0.05) in the type 2 diabetes group. CONCLUSION GLP-1 RA treatment significantly elevated eGFR, decreased the UACR, and positively influenced renal function outcomes in the type 2 diabetes group. CLINICAL TRIAL NUMBER Not applicable.
Collapse
Affiliation(s)
- Wenjing Li
- Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, 110004, China
- Department of Cardiology, Binzhou People's Hospital, Binzhou, Shandong Province, 256600, China
| | - Xiaoyan Liang
- Department of Central Laboratory, Binzhou People's Hospital, Binzhou, Shandong, 256600, China
| | - Na Sun
- Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, 110004, China
| | - Daqing Zhang
- Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
- Department of Cardiology, Shengjing Hospital of China Medical University, NO.36 Sanhao Street, Heping District, Shen Yang, Liaoning Province, 110004, China.
| |
Collapse
|
48
|
Størling R, Lilja C, Johansen R, von Arenstorff JF, Damsgaard TE. Go Pre or Stay Sub? Immediate implant-based breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2025; 106:131-144. [PMID: 40408844 DOI: 10.1016/j.bjps.2025.04.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2025] [Revised: 04/07/2025] [Accepted: 04/29/2025] [Indexed: 05/25/2025]
Abstract
AIM The aim of this study was to compare postoperative complications between pre- and subpectoral implant-based breast reconstruction in non-irradiated patients. METHODS This systematic review and meta-analysis was conducted following the preferred reporting items for systematic reviews and meta-analyses guidelines. Literature search was performed using the PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases. Meta-analysis assessed implant loss, while odds ratios (OR) were used to compare other postoperative complications, such as dehiscence, seroma, infection, necrosis, and re-operation. The Clavien-Dindo system was applied to standardize the comparison of complication severity. RESULTS The literature search identified 1087 studies. Eighteen met the inclusion criteria. A meta-analysis of 11 studies showed no significant difference in implant loss between the pre- (1045 cases) and subpectoral (1485 cases) groups (OR = 1.00, p > 0.99). Furthermore, the application of the Clavien-Dindo classification of postoperative complications revealed no significant differences in the severity or frequency of complications between the 2 implant placements. No significant differences were found for other postoperative outcomes including seroma, dehiscence, hematoma, infection, necrosis, and re-operation. CONCLUSION Pre- and subpectoral implant-based breast reconstruction have comparable outcomes for implant loss. There were no significant differences in the severity or frequency of complications when standardized using the Clavien-Dindo classification system. These findings suggest that prepectoral placement is as safe as subpectoral placement in appropriately selected patients. Future studies should focus on standardizing the reporting of complications to enhance comparability between sub- and prepectoral implant placement across studies, thereby improving surgical decision-making.
Collapse
Affiliation(s)
- Regitze Størling
- Department of Plastic Surgery, Odense University Hospital, Denmark.
| | - Caroline Lilja
- Department of Plastic Surgery, Odense University Hospital, Denmark
| | - Rikke Johansen
- Department of Plastic Surgery, Odense University Hospital, Denmark
| | | | - Tine Engberg Damsgaard
- Department of Plastic Surgery, Odense University Hospital, Denmark; University Hospital of Southern Denmark, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Denmark
| |
Collapse
|
49
|
Gemelli M, Rojanathagoon T, van den Eynde J, Italiano EG, Lena T, Pompeu Sá M, Bruno VD, Sandhu M, Pruna-Guillen R, Oo AY, Czerny M, Gallo M, Slaughter MS, Tarzia V, Mohamed Ahmed E, Rajakaruna C, Gerosa G. The German Registry of Acute Aortic Dissection Type A score for 30-day mortality prediction in Type A Acute Aortic Dissection surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2025; 67:ezaf138. [PMID: 40221854 DOI: 10.1093/ejcts/ezaf138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2025] [Revised: 03/19/2025] [Accepted: 04/11/2025] [Indexed: 04/15/2025] Open
Abstract
OBJECTIVES The German Registry of Acute Aortic Dissection Type A (GERAADA) score is a risk score for predicting 30-day mortality after an operation for type A acute aortic dissection (TAAAD). This meta-analysis sought to assess the performance of the GERAADA model and compare it to the performance of the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II). METHODS A systematic search of 3 online databases was conducted to identify studies that externally validated the GERAADA score. A random-effect meta-analysis was conducted, pooling area under the curve (AUC) data, operative mortality observed/expected (O/E) ratios and observed-expected (O-E) differences-of the GERAADA model in all studies and of the EuroSCORE II when available. RESULTS Eleven studies were selected, including a total of 10 360 patients. The observed in-hospital mortality rate was 12.2%. Pooled expected mortality rates estimated by the GERAADA score and the EuroSCORE II were 18.4% and 5.8%, respectively. The pooled analyses for the GERAADA scores showed moderate discrimination [AUC 0.70, 95% confidence interval (CI) 0.66-0.73] and good calibration [observed-expected (O-E) differences -12.3, 95% CI -27.1 to 2.58; O/E ratio 0.81, 95% CI 0.57-1.05]. Results from 5 studies (2133 patients) investigating both scores simultaneously revealed similar AUC results (P = 0.50), significantly lower O-E differences (P = 0.03) and a trend towards O/E ratios closer to 1 (P = 0.08) with the GERAADA score compared to the EuroSCORE II. CONCLUSIONS The GERAADA score seemed to offer a better calibration for predicting 30-day postoperative death following TAAAD operations, even though further studies are needed to confirm these findings. The moderate discriminatory capacity of both scores highlights the challenges of predicting outcomes in complex cardiovascular conditions like TAAAD.
Collapse
Affiliation(s)
- Marco Gemelli
- Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padova, Padova, Italy
- Cardiac Surgery, Bristol Heart Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
| | | | | | - Enrico G Italiano
- Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padova, Padova, Italy
| | - Tea Lena
- Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padova, Padova, Italy
| | - Michel Pompeu Sá
- Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Vito D Bruno
- Minimally Invasive Cardiac Surgery Unit, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy
| | - Manraj Sandhu
- Cardiac Surgery, Bristol Heart Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
| | - Robert Pruna-Guillen
- Department of Cardiothoracic Surgery, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK
| | - Aung Y Oo
- Department of Cardiothoracic Surgery, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK
| | - Martin Czerny
- Clinic for Cardiovascular Surgery, University Heart Center Freiburg Bad Krozingen, Bad Krozingen, Germany and Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany
| | - Michele Gallo
- Department of Cardiovascular and Thoracic Surgery, University of Louisville, KY, Louisville, USA
| | - Mark S Slaughter
- Department of Cardiovascular and Thoracic Surgery, University of Louisville, KY, Louisville, USA
| | - Vincenzo Tarzia
- Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padova, Padova, Italy
| | - Eltayeb Mohamed Ahmed
- Cardiac Surgery, Bristol Heart Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
| | - Cha Rajakaruna
- Cardiac Surgery, Bristol Heart Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
| | - Gino Gerosa
- Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padova, Padova, Italy
| |
Collapse
|
50
|
Dehzad MJ, Ghalandari H, Fahimzad FS, Maghsoudi Z, Makhtoomi M, Nouri M, Askarpour M. Effects of green tea supplementation on obesity indices and adipokines in adults: a grade-assessed systematic review and dose-response meta-analysis of randomised controlled trials. Int J Food Sci Nutr 2025:1-30. [PMID: 40326418 DOI: 10.1080/09637486.2025.2496400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2024] [Revised: 02/18/2025] [Accepted: 04/15/2025] [Indexed: 05/07/2025]
Abstract
BACKGROUND In this systematic review and meta-analysis, the impact of green tea supplementation on measurement/indices of adiposity was investigated. METHODS Using predefined keywords, online databases (PubMed, Scopus, Web of Science Core Collection, and Google Scholar) were searched for relevant studies, published from inception up to February 2024. Data were extracted and registered. Subgroup analyses and the investigation of linear and non-linear associations were carried out. RESULTS Green tea supplementation reduced BW (WMD: -0.74 kg; 95% CI: -0.97, -0.51), BMI (WMD: -0.29 kg/m2; 95% CI: -0.38, -0.19), WC (WMD: -1.04 cm; 95% CI: -1.55, -0.53), BFP (WMD: -0.65%; 95% CI: -1.03, -0.27), and leptin (WMD: -0.92 ng/ml; 95% CI: -1.71, -0.14), but did not change adiponectin levels (WMD: 0.20 µg/ml; 95% CI: -0.17, 0.57). CONCLUSION Supplementation with green tea seems to be effective in reducing excess adiposity.
Collapse
Affiliation(s)
- Mohammad Jafar Dehzad
- Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hamid Ghalandari
- Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Fatemeh Sadat Fahimzad
- Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Maede Makhtoomi
- Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mehran Nouri
- Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
| | - Moein Askarpour
- Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|